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INTRODUCTION 
Coronary heart disease (CHD) is the leading cause of 
death in Americans and is responsible for more deaths than 
all forms of cancer combined. Approximately 50% of all 
deaths in normal individuals and 75% of all deaths in 
diabetic individuals are a direct result of CHD. A large 
number of other individuals have undiagnosed coronary 
disease, thus increasing numbers of those with CHD even 
more. Atherosclerosis is most often associated^ with CHD, 
even though CHD involves all forms of micro- and 
macrovascular disease. Because heart disease is both life 
threatening and costly, over 6.5 billion dollars are spent 
per year in the U.S. on CHD, ways to defer its development 
must be studied. 
Saturated fat was first implicated in development of 
atherosclerosis in the mid-1950s and since that time the 
literature has been replete with studies on effects of type 
of dietary fat on atherosclerosis development. Even though 
some controversy still exists, the general agreement is that 
dietary saturated fat will lead to elevated plasma 
cholesterol concentrations. Lipid content and rate of 
accretion of lipid in tissues, however, are more directly 
related to atherosclerosis development than is plasma 
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cholesterol and need to be studied in addition to plasma 
cholesterol concentrations. 
Because of the interest on dietary fat in 
atherosclerosis development, effect of dietary fat on 
homeostasis of other metabolites, such as plasma glucose and 
insulin, largely have been ignored. Limited studies have 
demonstrated that different degrees of unsaturation of 
dietary fats will influence binding and action of insulin 
(Ginsberg et al., 1982; McCaleb and Donner, 1981; Gould et 
al., 1982) and concentrations of plasma insulin (Hulsmann 
and Kort, 1983; Weekes et al., 1986). Thus, dietary fats 
with different degrees of unsaturation may be important in 
regulation of glucose homeostasis in normal and diabetic 
animals. 
The objectives of the present study were 1) to 
determine if different types of dietary fat will influence 
glucose homeostasis in normal and diabetic pigs, 2) to 
elucidate the mechanism for hypercholesterolemia and 
hypertriglyceridemia in normal pigs fed saturated fat, 3) to 
elucidate the mechanism for hypercholesterolemia and 
hypertriglyceridemia in diabetics and 4) to determine if 
different types of dietary fat will influence lipid 
homeostasis in diabetics. 
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REVIEW OF LITERATURE 
Lipoprotein Metabolism 
Lipids are transported in plasma of warm-blooded 
animals and birds as lipoproteins, which are water-soluble 
particles comprised of nonpolar lipids, polar lipids, and 
protein (Havel, 1972). The nonpolar components, 
triglyceride and cholesterol esters, are located in a 
hydrophobic core of the particle. Polar lipids, cholesterol 
and phospholipids, and protein form a hydrophilic shell 
around the hydrophobic core, making the insoluble lipid 
water-soluble (Havel, 1972) . 
There are several classes of lipoproteins: very low 
density lipoproteins (VLDL), chylomicrons, intermediate 
density lipoproteins (IDL), low density lipoproteins (LDL), 
and high density lipoproteins (HDL). Each lipoprotein class 
is characterized by amount of lipid and protein and, thus, 
by density. 
VLDL and chylomicron composition 
The two classes of lipoproteins that are the primary 
carriers of triglycerides are VLDL and chylomicrons. Very 
low density lipoproteins transport endogenous triglycerides 
from liver to extrahepatic tissues. They are comprised of 
about 90% lipid (60% triglyceride, 12% cholesterol, and 18% 
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phospholipid) and 10% apolipoprotein (apoB, apoC, and apoE) 
and have a density in the range of 0.96-1.006 g/ml. 
Chylomicrons transport dietary triglyceride from the small 
intestine to the rest of the body. Chylomicrons are 
comprised of about 98% lipid (90% triglyceride, 5% 
cholesterol, and 3% phospholipid) and 2% apolipoprotein 
(apoB and apoC) with a density less than 0.96 g/ml (Scanu, 
1983) . 
VLDL and chylomicron synthesis and secretion 
Very low density lipoproteins are synthesized most 
often in the liver. A small percentage of VLDL is 
synthesized in the small intestine, primarily during fasting 
(Byers and Friedman, 1960; Cendella et al., 1974). 
Synthesis and secretion of VLDL are similar in the two 
tissues and occur by way of a series of membrane-bound 
compartments similar to those for other secretory proteins 
(Alexander et al., 1976). Apolipoproteins of VLDL are 
synthesized in the rough endoplasmic reticulum and are 
transported to smooth endoplasmic reticulum where the 
apolipoproteins associate with non-polar lipids, primarily 
triglycerides (Janero and Lane, 1983). The VLDL-like 
particles transverse to the Golgi apparatus where 
phospholipids and cholesterol are added to the outer shell. 
In Golgi-derived secretory vesicles, nascent VLDL are 
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shuttled to the plasma membrane and released into blood 
(Janero and Lane, 1983; Higgins and Hutson, 1984; Janero et 
al., 1984) . 
Chylomicrons are synthesized in small intestine. 
Components of this lipoprotein are derived primarily from 
exogeneous, dietary sources. During fasting, however, 
lipids and proteins are synthesized in the small intestine 
and used for VLDL synthesis (Shiau et al., 1985). 
Chylomicrons and VLDL of mucosal cells are synthesized and 
packaged similarly to VLDL of hepatocytes; the two 
intestinal lipoproteins are packaged and secreted into the 
lymphatic system separately from one another (Thomson, 1978; 
Tso et al., 1984). 
Many effectors of VLDL and chylomicron synthesis exist, 
the most important being substrate availability. Hepatic 
fatty acids (Reaven and Greenfield, 1981; Fukuda and Ontko, 
1984; Kazumi et al., 1985) and phospholipids (Mansbach et 
al., 1985) are the primary regulators of VLDL synthesis and 
secretion; insulin is reguired as a permissive factor for 
VLDL secretion (Reaven and Greenfield, 1981). Primary 
effectors of chylomicron synthesis are dietary sources of 
lipid (Zilversmit, 1978). 
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VLDL and chylomicron catabolism 
Catabolism of VLDL and chylomicrons, like their 
synthesis, is a multi-step process. The enzyme that 
catalyzes hydrolysis of a majority of the triglyceride in 
lipoproteins is lipoprotein lipase (LPL; EC 3.1.1.3). 
Lipoprotein lipase is synthesized intracellularly and 
secreted to the endothelial lining of blood vessels of 
several tissues, such as adipose tissue, heart, skeletal 
muscle, and aorta. As apoC-II-containing lipoproteins, VLDL 
and chylomicrons, pass by LPL, they become bound to the 
enzyme, which is located in the lumen of blood vessels. 
ApoC-II-activated LPL catalyzes hydrolysis of triglycerides 
of lipoproteins to monoglycerides and free fatty acids. The 
hydrolyzed products of LPL activity cross the endothelial 
lining of blood vessels, enter the cells, and are stored as 
triglycerides or are oxidized. The removal of triglycerides 
from VLDL and chylomicrons does not occur all at once. 
Several different LPL molecules, located at different areas 
of the body, are involved in the hydrolysis of one 
lipoprotein particle (Cryer, 1981; Quinn et al., 1982). 
Hepatic lipase is another enzyme, similar to LPL, that 
plays an important role in catabolism of 
triglyceride-containing particles. This enzyme, which is 
similar to LPL, is located on endothelial lining of 
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capillaries in liver. Hepatic lipase catalyzes hydrolysis 
of triglycerides of VLDL and chylomicrons similarly to LPL 
(Murase and Itakura, 1981), but its exact role in metabolism 
of triglyceride-carrying lipoproteins is still relatively 
unclear (Kinnunen, 1984) . 
As VLDL undergo delipidation by LPL, they become more 
dense; dense VLDL are IDL. The constituents of IDL are the 
same as VLDL; the difference between the two lipoproteins is 
that IDL have less triglyceride than do VLDL. As more 
triglycerides are removed from the core of the IDL, by way 
of LPL activity, the outer shell of the lipoprotein begins 
to buckle and fold into a star-like configuration. The 
projections, comprised of protein, phospholipids, and 
cholesterol, are transferred to HDL, leaving smaller, 
spherical lipoproteins. The composition of this new, denser 
lipoprotein is that of LDL (Hamilton, 1978; Eisenberg, 
1984). 
Conversion of VLDL to IDL and finally to LDL occurs in 
plasma of normal humans (Bilheimer et al., 1972; Sigurdsson 
et al., 1975; Reardon et al., 1978; Reardon and Steiner, 
1982). In most other animals, such as pig (Hannan et al., 
1980; Huff and Telford, 1985) and rat (Baker and Schotz, 
1964) and in hypertriglyceridemic humans (Oschry et al., 
1985), IDL are removed from plasma primarily by the liver; 
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LDL subsequently are synthesized and secreted from liver as 
newly synthesized particles. 
Catabolism of chylomicrons is similar to that of VLDL. 
Lipoprotein products of chylomicron hydrolysis are 
chylomicron remnants and are "mirror images" of IDL and LDL 
(Cryer, 1981). Chylomicron remnants are taken up intact by 
tissues of most animals (Lippiello et al., 1985; Van Lenten 
et al., 1985) . 
Removal of VLDL, chylomicrons, and their products from 
the blood stream occurs by way of receptor-dependent and 
receptor-independent processes. Little is known about the 
receptor-independent process. There are three major 
receptor-dependent processes, and they are distinguishable 
from one another by their specificity for certain 
apolipoproteins (Mahley and Innerarity, 1983; Shepherd and 
Packard, 1986). 
The LDL receptor is probably the most widely studied 
lipoprotein receptor. It is an apoB,E receptor and has been 
described in detail by Brown and Goldstein (1984). 
Chylomicron remnants and IDL, in addition to LDL, bind to 
this receptor (Bradley and Gianturco, 1986). Receptors for 
LDL are present in all tissues except nervous tissue 
(Miller, 1979), with a majority of receptor activity 
ocurring in the liver (Dietschy et al., 1983; Dietschy, 
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1984). Because most receptor activity is in the liver, the 
main route of cholesterol removal occurs by way of the liver 
as bile acids, which are synthesized primarily in liver 
(Salen and Shefer, 1983). 
A second type of receptor involved in VLDL removal from 
plasma binds and internalizes VLDL before delipidation. 
These receptors have been found on hepatocytes (Gustafson et 
al., 1985). Little research has been done to determine 
which apolipoproteins are required for binding of 
lipoproteins to this receptor. 
A third type of receptor that removes 
triglyceride-laden lipoproteins binds chylomicron remnants 
and cholesterol-laden VLDL. These receptors are found on 
hepatocytes and possibly macrophages and are specific for 
apoE (Mahley et al., 1981; Hui et al., 1984; Jones et al., 
1984; Van Lenten et al., 1985). For an excellent review on 
the role of lipoprotein uptake and processing by liver, see 
the article written by Havel (1985). 
Because the mechanism of LDL binding to the LDL 
receptor, internalization of LDL, and processing of LDL by 
cells is the most elucidated lipoprotein receptor mechanism, 
it will be the only mechanism reviewed here. After 
lipoproteins bind to receptors, lipoprotein receptor 
complexes aggregate in clathrin-coated pits. The pits 
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undergo endocytosis and fuse together. Because of the 
acidic nature of the newly formed endosomes, lipoproteins 
dissociate from receptors. Most receptors are recycled to 
the plasma membrane, and lipoproteins are transported to 
lysosomes where they are catabolized fully. The resultant 
amino acids, fatty acids, glycerol, and cholesterol are 
either used by the cell or are repackaged as new lipoprotein 
particles (Havel, 1985). Lipoprotein-derived cholesterol 
released from lysosomes is important in that it will 
regulate both de novo synthesis of cholesterol and 
translation of mRNA for LDL receptor by the cell (Brown and 
Goldstein, 1978, 1983). 
High density lipoprotein metabolism 
High density lipoproteins are synthesized and secreted 
by liver. Nascent, disc-shaped HDL contain little lipid and 
protein; they acquire most of their constituents from other 
tissues and from other lipoproteins. High density 
lipoproteins obtain free cholesterol from tissues, free 
cholesterol and phospholipids from VLDL, and apoA from 
chylomicrons. The esterification of HDL cholesterol to form 
cholesterol esters is catalyzed by lecithin cholesterol 
acyltransferase (LCAT; EC 2.3.1.43), an enzyme located on 
the lipoprotein. As HDL acquire more cholesterol and 
cholesterol esters, the discoidal shape becomes more 
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spherical. Subsequently, some of the cholesterol esters are 
transferred from HDL to VLDL and chylomicron remnants by 
transfer proteins, making the HDL discoidal again. High 
density lipoproteins also become discoidal after removal of 
cholesterol esters by liver (Hamilton, 1978; Rudel et al., 
1983; Eisenberg, 1984). 
Pig as a Human Model 
The domestic pig (Sus domesticus) has been used by many 
as a model animal for several human diseases because of the 
similar physiology and anatomy of digestive and 
cardiovascular systems of pigs and humans (Dodds, 1982). 
Specifically, pigs have been used as model animals in 
studies on obesity (Houpt et al., 1979) and atherosclerosis 
(Vesselinovitch, 1979). Their relatively large size allows 
one to take repeated blood samples from the same animal and 
allows for samples of small tissues, such as aorta. 
Vesselinovitch (1979) has reviewed the usefulness of 
pigs as an animal model for humans in atherosclerosis and 
lipoprotein metabolism. Pigs develop atherosclerotic 
lesions both spontaneously (Gottlieb and Lalich, 1954; Skold 
and Getty, 1961) or as a result of dietary manipulations 
(Reiser et al., 1959; Reitman et al., 1982). The lesions 
formed in pigs are similar in composition and formation to 
those in humans (Fritz et al., 1980). Fidge (1973) and 
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Terpstra and Beynen (1984) have found that composition of 
lipoproteins of pigs is very similar to that of humans, and, 
when fed a hypercholesterolemia diet, changes in lipoprotein 
composition of pigs occur that are similar to changes in 
humans fed high cholesterol diets (Reitman and Mahley, 
1982) . 
There are also some disadvantages to the use of pigs as 
a model animal for lipid disorders in humans. Pigs 
synthesize a majority of their fatty acids in adipose tissue 
(O'Hea and Leveille, 1969; Huang and Kummerow, 1976), and 
humans synthesize most of their fatty acids in liver (Patel 
et al., 1975). Thus, VLDL synthesis and secretion are more 
extensive in humans. Also, humans have two transfer 
proteins that shuttle triglycerides and cholesterol esters 
between lipoprotein classes; a different transfer protein is 
specific for each lipid (Hopkins and Barter, 1980). Pigs do 
not have transfer proteins for either triglycerides or 
cholesterol esters (Barter et al., 1982). Finally, in 
normal humans, most VLDL is converted to LDL in plasma. In 
pigs, LDL are synthesized in liver and secreted as nascent 
particles into the blood stream (Sigurdsson et al., 1975; 
Reardon et al., 1978; Huff and Telford, 1985). In a recent 
review of literature by Havel (1984), however, it was 
concluded that humans may be more like other animals than 
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first believed, and humans may synthesize nascent LDL 
particles in liver like other animals. 
The pig also has been used as a model animal for 
studies in type I diabetes in humans with the use of 
alloxan. Treatment with alloxan will result in preferential 
destruction of beta cells and will result in elevated plasma 
glucose concentrations, elevated plasma free fatty acid 
concentrations, and decreased plasma insulin concentrations 
(Romsos et al., 1971; Gabel et al., 1985). 
Atherosclerosis Development 
Atherosclerosis is any process that affects the 
arterial wall either through alterations in intracellular 
components, such as triglycerides and cholesterol esters, or 
alterations in extracellular components, such as collagen 
and fibrin. Early arterial wall damage involves mostly 
intracellular changes, whereas severe plaque formation 
involves a combination of intracellular and extracellular 
changes. Atherosclerotic plaque development in humans is 
normally a slow process. For reviews on atherosclerosis 
development, see Ganda (1980), Fielding (1981), and Moore 
(1985). 
The first step in development of plaque is a breakdown 
of the endothelial lining, which acts as a barrier between 
blood and smooth muscle cells. Blood constituents, such as 
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lipoproteins and platelets, enter the damaged arterial wall 
and come in contact with smooth muscle cells (Schwartz, 
1980). Platelets aggregate at the damaged area and release 
a platelet-derived growth factor that stimulates cell 
proliferation (Schwartz and Ross, 1984). As smooth muscle 
cells proliferate, they also accumulate lipids. Macrophages 
enter the damaged area and also begin to accumulate lipids. 
Thus, foam cells, which are lipid-laden smooth muscle cells 
and macrophages, begin to develop (Brown and Goldstein, 
1984) . 
Lipid accretion occurs in smooth muscle cells and 
macrophages by several mechanisms. Lipoprotein receptors 
are present on both smooth muscle cells and macrophages; 
smooth muscle cells have apoB,E receptors and macrophages 
have apoB,E and apoE receptors (Brown and Goldstein, 1983; 
Van Lenten et al., 1985). In addition to functional LDL 
receptor activity, smooth muscle cells have functional LPL 
activity. Zilversmit (1973, 1979) believes that LPL 
activity in this vicinity is a leading contributor to 
atherosclerosis development. The hypothesis is that 
remnants are liberated in the vicinity of arterial 
endothelium after hydrolysis of VLDL and chylomicrons by LPL 
and subsequently are taken up by receptors on smooth muscle 
cells and macrophages (Pitas et al., 1983). Uptake of 
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remnants would be enhanced because of the high concentration 
of remnants in the vicinity of the receptors (Zilversmit, 
1973) . 
Effects of Different Dietary Fats on Lipoprotein Metabolism 
and Atherosclerosis 
Coronary heart disease, specifically atherosclerosis, 
is the leading cause of death in the U. S. 
Hypertriglyceridemia and hypercholesterolemia often times 
occur in conjunction with atherosclerosis and are considered 
to be two major risk factors of the disease. Different ways 
to manipulate plasma triglyceride and cholesterol 
concentrations, such as by diet, always are being evaluated 
to find a "cure" for atherosclerosis (Havel, 1983; 
Kritchevsky, 1983; Samuel et al., 1983). 
Studies on effect of amount and type of dietary fat on 
plasma lipid concentrations and composition started in the 
mid-1950s. Nichols et al. (1957) and Hatch et al. (1955) 
demonstrated that high carbohydrate, low fat diets resulted 
in hypertriglyceridemia in which VLDL were the primary 
triglyceride carriers (Liu et al., 1983; Kazumi et al., 
1985). Evidently, both triglyceride and apolipoprotein 
synthesis is elevated in hepatocytes of animals fed high 
carbohydrate, low fat diets, which result in increases in 
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VLDL synthesis and secretion (Boogaerts et al., 1984; Kazumi 
et al., 1985). 
Occurring concurrently with an increase in VLDL 
secretion in animals fed high carbohydrate, low fat diets is 
an increase in removal of VLDL by tissues. Activity of LPL 
in white adipose tissue (Pokrajac and Lossow, 1967; 
deGasquet et al., 1977; Granneman and Wade, 1983) and uptake 
of triglyceride-containing lipoprotein remnants by liver 
(Kortz et al., 1984) was increased in animals fed high 
carbohydrate, low fat diets, resulting in increased removal 
of VLDL-triglyceride. 
Effect of type, in addition to amount, of dietary fat 
on plasma triglyceride concentrations also has been 
evaluated. Baudet et al. (1984), Oh and Monaco (1985), 
Shepherd et al. (1980), and Schonfeld et al. (1982) found a 
decrease in plasma triglyceride concentrations in animals 
fed diets high in polyunsaturated fatty acids (PUFA). The 
changes in plasma triglycerides most often occurred as VLDL. 
Still unknown is whether differences in VLDL-triglyceride 
concentrations in animals fed different types of fat are the 
result of changes in secretion or removal of VLDL. Several 
investigators have studied effects of type of dietary fat on 
LPL activity; increases (Bagdade et al., 1970, Cryer et al., 
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1978), decreases (Paik and Yearick, 1978), or no changes 
(Lawson et al., 1981) have been found. 
Effect of type of dietary fat on plasma cholesterol 
concentrations has caused much more of a controversy than 
has effect of type of dietary fat on plasma triglyceride 
concentrations. It is commonly accepted that dietary PUFA 
lower plasma cholesterol; however, which lipoprotein class 
this change occurs in is still a widely-disputed topic. 
Grundy and Ahrens (1970) and Oh and Monaco (1985) have shown 
that diets high in PUFA will result in a decrease in 
LDL-cholesterol only. These results are not consistent with 
others, however, because Mattson and Grundy (1985), Jackson 
et al. (1984), and Rudel et al. (1983) have shown that high 
PUFA diets result in decreases in both LDL-cholesterol and 
HDL-cholesterol. Brussard et al. (1980) found an increase 
in HDL-cholesterol with a decrease in LDL-cholesterol of 
PUFA-fed animals. 
In addition to effects on cholesterol and triglyceride 
concentrations, type of dietary fat affects composition of 
fatty acids and apolipoproteins of lipoproteins. Shore et 
al. (1983) found that fatty acid composition of lipoproteins 
follows the same pattern as does the fatty acid composition 
of diets. In addition, protein content, specifically apoB, 
of VLDL are elevated in animals fed saturated fat (Baudet et 
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al., 1984; Renner et al., 1986); lipoproteins from animals 
fed different fats even appear structurally different when 
observed with an electron microscope (Feldman et al., 1983). 
Lipoproteins from animals fed saturated fat were flatter 
when compared with lipoproteins from animals fed PUFA. 
Similar to that of lipoproteins, fatty acid composition 
of plasma membranes is influenced by type of dietary fat. 
Composition of fatty acids of plasma membranes resemble the 
fatty acids of the diet (Blomstrand et al., 1985; 
Popp-Snijders et al., 1986). Differences in fatty acid 
composition and fluidity of plasma membrane will affect 
intramembrane protein function, such as lipoprotein 
receptor, or passive diffusion of fatty acids and 
cholesterol across plasma membranes and, thus, could have a 
large influence on lipoprotein metabolism. Recently, Spady 
and Dietschy (1985) demonstrated that LDL receptor function 
was obliterated in animals fed saturated fat in comparison 
with animals fed PUFA. This change evidently was because of 
a change in plasma membrane composition. 
Cholesterol content in membranes changes as a result of 
changes in fluidity of plasma membranes. Cholesterol is 
added to plasma membranes in order to make them more rigid 
(Kummerow, 1983; Spector and Yorek, 1985). In pigs 
(Forsythe et al., 1980), rats (Awad, 1981), and squirrel 
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monkeys (Lofland et al., 1970) fed PUPA, increased 
cholesterol was found in aortas when compared with animals 
fed saturated fat, and this change possibly occurred as the 
result of a change in plasma membrane composition in animals 
fed PUPA. 
Insulin 
structure, biosynthesis, and secretion 
Insulin is synthesized in the endoplasmic reticulum of 
pancreatic beta cells by a mechanism similar to that of 
other secretory proteins (Steiner et al., 1974). The leader 
sequence of preproinsulin is cleaved as it enters the 
endoplasmic reticulum. The resultant proinsulin is 
transported to the Golgi appartus and packaged into 
secretory granules. While in the endoplasmic reticulum, the 
polypeptide is folded into the proper conformation of 
proinsulin. The internal section of proinsulin, C-peptide, 
is cleaved, leaving a protein (insulin) containing two 
chains of amino acids linked by two disulfide bridges. 
Insulin and C-peptide are released from beta cells in a 1:1 
molar ratio. About 50% of the insulin is taken up and 
degraded during the first pass through the liver (Samols and 
Ryder, 1961; Rubenstein et al., 1972b). C-peptide is not 
taken up and degraded by liver, but by kidney (Rubenstein et 
20 
al., 1972a), and thus its concentration in blood can be used 
to estimate insulin secretion (Horwitz et al., 1975). 
Several mechanisms have been proposed to account for 
release of insulin by pancreatic cells. Responsible for 
stimulation of insulin secretion is acidification of islet 
cells produced as a consequence of intracellular catabolism 
of nutrients (Deleers et al., 1985), cytosolic NADPH to 
NADP+ ratios (Sener et al., 1984), ionic calcium (Vydelingum 
et al., 1978; Phang et al., 1984), and arachidonic acid 
catabolism (Turk et al., 1985; Metz, 1985). Nutrient 
substrates, such as carbohydrate, protein, and fat, affect 
secretion of insulin either directly or indirectly. 
Carbohydrates, specifically glucose, affect insulin 
secretion more than any other compound. To be more precise, 
metabolism of intracellular glucose by pancreas, and not 
glucose per se or glucose binding to the beta cells, is 
coupled to insulin secretion (Grodsky et al., 1963; 
Garfinkel et al., 1984). 
Oral glucose stimulates insulin secretion to a greater 
degree than does intraveneously administered glucose; this 
difference is a result of oral glucose stimulating secretion 
of intestinal hormones, which also stimulate insulin 
secretion. The intestinal hormone with the most potent 
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ability to stimulate insulin secretion is gastric inhibitory 
polypeptide (GIF; Dupre et al., 1973). 
Other types of dietary components, such as amino acids 
and fats, also affect insulin secretion more when given 
orally than when infused. Dietary protein and amino acids, 
especially arginine and leucine, stimulate insulin secretion 
both directly and by way of intestinal hormone secretion 
(Schulz et al., 1982; Yoros et al., 1982). Dietary fat 
stimulates insulin secretion only through an indirect 
mechanism by way of GIF (Falko et al., 1972; Hampton et al., 
1983). 
Insulin secretion is influenced by other hormones 
besides the aforementioned intestinal hormones. Hormones 
that mediate their activity by way of cAMP, such as glucagon 
and 3-adrenergic agonists, stimulate insulin secretion by 
increasing intracellular concentrations of Ca+2 (Vydelingum 
et al., 1978; Phang et al., 1984; Korman et al., 1985). A 
good review on insulin secretion has been written by Pfeifer 
et al. (1981). 
Actions of insulin 
The first step in the action of insulin is to bind to 
receptors on plasma membranes. After binding to the 
receptor, the insulin-receptor complexes aggregate into 
coated pits and are taken into cells by endocytosis. Either 
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insulin is degraded in lysosomes and receptors 
re-exteriorized or the whole receptor-insulin complex is 
re-exteriorized (Marshall, 1985a; Marshall, 1985b). 
Binding of insulin to the receptor, and not 
internalization, seems to be required for insulin to exert 
its effect on intracellular metabolism. A mediator, like 
cAMP, probably is involved in action of insulin. Several 
groups have isolated and partially characterized a 
metabolite believed to be the mediator of insulin action 
(Walaas and Horn, 1981; Jarett et al., 1982; Larner et al., 
1982; Seals and Czech, 1982; Cheng and Larner, 1985; Parker 
and Jarett, 1985). 
Insulin influences metabolism of both hepatic and 
extrahepatic tissues and results in an anabolic state in 
liver, adipose tissue, skeletal muscle, and heart. In 
liver, insulin stimulates glycolysis, glycogenesis, and 
lipogenesis. Specifically, insulin induces synthesis of 
glucokinase, allowing greater uptake of glucose into 
hepatocytes, and of pyruvate kinase, allowing for greater 
rates of glycolysis. Insulin promotes dephosphorylation of 
phosphorylatable enzymes, such as glycogen phosphorylase, 
glycogen synthase, phosphofructokinase, pyruvate kinase, 
pyruvate dehydrogenase, acetyl-CoA carboxylase, and 
3-hydroxy 3-methylglutaryl-CoA reductase. These enzymes are 
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active when dephosphorylated except for glycogen 
phosphorylase, which is active when phosphorylated. 
In addition to the direct effect of insulin on activity 
of enzymes involved in glycolysis, glycogenesis, and 
lipogenesis, insulin also has an indirect effect on these 
processes by enhancing formation of metabolites that 
allosterically modulate metabolite fluxes through several 
metabolic pathways. For example, intracellular 
concentrations of fructose-1,6-diphosphate, a positive 
allosteric effector of pyruvate kinase, pyruvate, a positive 
effector of pyruvate dehydrogenase, and citrate, a positive 
effector of acetyl-CoA carboxylase, are elevated when 
insulin is present; these changes help maintain hepatocytes 
in a state of anabolism. 
In peripheral tissues, insulin has several effects. 
First, insulin enhances uptake of glucose by increasing 
activity of transport mechanisms. In addition, glucose 
utilization is enhanced by increasing rates of glycolysis 
and lipogenesis in adipose tissue and by increasing 
glycolysis and glycogenolysis in skeletal muscle. Insulin 
also stimulates triglyceride deposition in adipose tissue by 
increasing LPL activity and by inhibiting hormone-sensitive 
lipase activity, which is an enzyme that needs to become 
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phosphorylated to be active (Harris, 1982; Harris and Crabb, 
1982) . 
Counter-regulatory hormones 
The lowering of plasma glucose concentrations by 
insulin is regulated closely by several counter-regulatory 
hormones that help maintain plasma glucose concentration. 
The primary counter-regulatory hormones are glucagon, 
catecholamines, Cortisol, and growth hormone (Eaton and 
Schade, 1978). Glucagon is the counter-regulatory hormone 
correlated most closely on a day-to-day maintanance basis 
with insulin (Unger, 1971). The main function of 
catecholamines, Cortisol, and growth hormone are during 
times of stress and when plasma glucose is lowered by more 
than 20 or 30 mg percent (Eaton and Schade, 1978). 
Glucagon affects metabolism of hepatic and extrahepatic 
tissues by stimulating the phosphorylation of key regulatory 
enzymes and switching tissues to a state of catabolism. 
Tissues are affected indirectly by glucagon because of the 
influence that glucagon has on allosteric effectors of 
metabolism. In liver, glucagon enhances concentrations of 
fatty acyl-CoA, acetyl-CoA, and citrate, which inhibit 
acetyl-CoA carboxylase, pyruvate dehydrogenase, and 
phosphofructokinase, respectively. Uptake of gluconeogenic 
precursors by liver, such as amino acids, is enhanced by 
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glucagon. The liver is supplied with more gluconeogenic 
precursors because glucagon stimulates protein catabolism in 
skeletal muscle. Furthermore, glucagon stimulates 
lipolysis, which will supply liver with more fatty acids to 
be oxidized for energy and with more glycerol to be used for 
gluconeogenesis. Thus, glucagon promotes the body to be in 
a state of catabolism as a mechanism to elevate plasma 
glucose concentration (Mackrell and Sokal, 1969; Harris, 
1982; Harris and Crabb, 1982). 
Diabetes 
Diabetes has been classified as either type I or type 
II diabetes. Type I diabetes or juvenile-onset diabetes 
usually occurs in individuals under 25 years of age. This 
type of diabetes is associated with a lack of insulin, 
usually from a lack of functional beta cells. Patients with 
type I diabetes are said to have insulin-dependent diabetes 
mellitus (IDDM). Type II diabetes or maturity-onset 
diabetes usually occurs in individuals over 40 years of age. 
This type of diabetes commonly is associated with 
hyperinsulinemia, obesity, and insulin resistance. Patients 
with this type of diabetes are said to have 
noninsulin-dependent diabetes mellitus (NIDDM). About 5% of 
the total U.S. population is diabetic. Of this incidence. 
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about 10% of the diabetics are type I and 90% are type II 
(Coughlin and Kahn, 1986). 
Definition of diabetes and development of type I diabetes 
There are numerous defects in metabolism of diabetics, 
but the two most underlying defects are decreased uptake of 
glucose by peripheral tissues and increased hepatic 
gluconeogenesis. Diabetics are literaly "starving in the 
midst of plenty" because, even though there is an excess of 
extracellular glucose, a deficiency of intracellular glucose 
exists. 
The primary cause of the lack of functional insulin in 
patients with IDDM is a lack of functional beta cells in the 
pancreas from pathogenic (Rerup, 1970; Wilson et al., 1984), 
immunologic (Kannazawa et al., 1984; Ziegler et al., 1984), 
genetic (Leiter, 1984), or viral (Notkins, 1979) destruction 
of pancreatic cells. Lack of beta cells is not the only 
reason for a decrease of functional insulin in IDDM, 
however. In some individuals with IDDM, beta cells are 
functional; antibodies are made against insulin, rendering 
the secreted insulin ineffective (Tager, 1984; Palmer et 
al., 1983). 
An excess of glucagon almost always accompanies the 
lack of insulin in type I diabetes because, without insulin, 
no inhibition of glucagon secretion occurs (Unger and Orci, 
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1981). The resultant high ratio of glucagon to insulin 
leads to a catabolic state of the body in an attempt to 
elevate plasma glucose. In untreated diabetics, 
triglycerides and fatty acids are oxidized for energy and 
result in an excess of acetyl-CoA, which is used for 
synthesis of ketone bodies. An excess of ketones in plasma 
lowers the pH of the blood and, if untreated, will lead to 
ketoacidosis. Exogeneous insulin, therefore, is essential 
for the diabetic to maintain pseudo-normal conditions and 
prevent ketoacidosis. 
Often times, the amount of insulin required to maintain 
normal glucose concentrations in diabetics is greater than 
would be expected, implying that tissues are resistant to 
insulin. Pedersen and Hjollund (1982), DeFronzo et al. 
(1982), and Del Prato et al. (1983) have shown cells and 
tissues to be resistant to insulin in IDDM. Del Prato et 
al. (1983) and Corin and Donner (1982) have shown that the 
insulin resistance in IDDM is primarily because of a 
post-receptor defect. Pedersen and Hjollund (1982) have 
shown that the resistance is the result of a combination of 
a defect in post-receptor metabolism and in insulin binding. 
Diabetes and Atherosclerosis 
Atherosclerosis is the major cause of death in 
diabetics (Ganda, 1980). Several major risk factors for 
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atherosclerosis, such as hyperglycemia, hypertension, and 
hyperlipidemia, often are associated with both type I and II 
diabetes. Exogeneous insulin and dietary modifications will 
correct hyperglycemia to a large degree. Hyperlipidemia, on 
the other hand, is not corrected by exogeneous insulin to 
the same extent as is hyperglycemia (Sosendo et al., 1980; 
Glasgow et al., 1981). 
In diabetic hyperlipidemia, the most consistent 
alteration in plasma lipids is an elevation in 
VLDL-triglycerides (Van Toi, 1977; Chen et al., 1979; Reaven 
and Greenfield, 1981; Briones et al., 1984), even though at 
times triglyceride and cholesterol concentrations are 
elevated in all lipoprotein classes (Bar-On et al., 1976; 
Wilson and Brown, 1978). Changes that occur in other 
lipoprotein classes, such as LDL-cholesterol, are most 
likely a secondary effect of increases in VLDL. After 
reviewing the recent literature, Chen et al. (1980) came to 
the conclusion that the cause of hypertriglyceridemia in 
diabetes is because of alterations in both removal and 
secretion of VLDL-triglycerides. 
Very low density lipoprotein-triglyceride hydrolysis, 
and thus removal of VLDL-triglycerides from plasma, is 
catalyzed by LPL activity. Adipose tissue LPL activity, 
which is stimulated by insulin, removes a majority of plasma 
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triglycerides. A lack of LPL activity results in a decrease 
in removal of VLDL-triglycerides from plasma and, hence, 
leads to elevated triglyceride concentrations (Cryer, 1981). 
Because insulin stimulates LPL activity in adipose tissue, a 
lack of insulin results in a lack of LPL activity (Cryer, 
1981). Nikkila et al. (1977) and Brunzell et al. (1979) 
demonstrated that type I diabetics have depressed activity 
of LPL in adipose tissue, which could contribute to 
formation of hypertriglyceridemia (Chen et al., 1979; Reaven 
and Greenfield, 1981). Treatment of diabetic patients with 
insulin results in an increase and decrease in LPL activity 
and plasma lipids, respectively (Taskinen et al., 1981). 
The depressed LPL activity measured in diabetics can 
not entirely account for the elevation in plasma 
triglyceride concentrations (Chen et al., 1979); secretion 
of VLDL-triglycerides must be altered in diabetics also. 
Plasma free fatty acid concentration, which is elevated in 
diabetics, has a large influence on VLDL-triglyceride 
secretion rates. Insulin, however, must be present as a 
permissive hormone for this effect to occur (Woodside and 
Heimberg, 1972; Reaven and Greenfield, 1981). In patients 
with IDDM, there may be enough insulin to stimulate 
VLDL-triglyceride secretion when found in combination with 
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elevated free fatty acid concentration (Reaven and 
Greenfield, 1981). 
Hyperlipidemia and hyperglycemia in diabetics are 
treated with insulin. Because insulin is administered 
subcutaneously, a much higher dose of insulin is 
administered than would have been if the insulin were 
administered intraportally. The resultant, peripheral 
hyperinsulinemia, given to control diabetic hyperglycemia 
and hyperlipidemia, actually could accelerate 
atherosclerosis development because insulin stimulates 
smooth muscle cell proliferation of arterial cells (Stout, 
1981; Nakao et al., 1985); proliferation of smooth muscle 
cells is believed to be the first step in atherosclerosis 
development (Stout, 1981). Exogeneous insulin also 
stimulates lipogenesis in arterial cells, which results in 
furthur lipid accretion in those cells (Capron et al., 1984; 
Falholt et al., 1985). 
Dietary treatment, type II diabetes formation, and control 
of type I diabetes 
Just as diet is believed to influence atherosclerosis 
development, diet also could influence type II diabetes 
formation. The sequence of events leading to development of 
type II diabetes is not well elucidated. One theory is that 
diabetes formation begins as resistance of tissues to 
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insulin either by defects in insulin binding and/or 
post-receptor mechanisms (Olefsky, 1981; Orchard et al., 
1983; Reaven, 1984). Hyperinsulinemia will follow insulin 
resistance to compensate for the defects in insulin 
function. 
Alternatively, hyperinsulinemia could be the primary 
defect in diabetes development. Down regulation of 
receptors would follow the hyperinsulinemia (Soman and 
DeFronzo, 1980), which subsequently would lead to insulin 
resistance and to a more exaggerated case of 
hyperinsulinemia. Thus, any secretogues of insulin have the 
ability to potentiate NIDDM formation. In a recent study, 
rats fed saturated fat in comparison to rats fed PUFA had 
greater concentrations of plasma insulin in response to a 
meal. Greater concentrations of plasma GIF also were found 
in plasma of rats fed saturated fat (Hulsmann and Kort, 
1983). Hulsmann and Kort (1983) have postulated that 
saturated fat may be absorbed from the intestine more slowly 
than PUFA and that GIF secretion is stimulated for a longer 
time period in animals fed saturated fat; these changes 
could lead to hyperinsulinemia. 
In addition, type of dietary fat can affect insulin 
receptor function directly, thus affecting type II diabetes 
formation. As previously mentioned, the binding of insulin 
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to its receptor is the first step in activation of 
intracellular mechanisms. If the receptor is not functional 
because of changes in physical characteristics of the plasma 
membrane, there will be less efficient binding and 
subsequent loss of activation of intracellular metabolic 
processes by insulin (Amatruda and Finch, 1979; Olefsky, 
1981). 
Because type of dietary fat alters plasma membrane 
composition and characteristics (Blomstrand et al., 1985; 
Popp-Snijders et al., 1986), type of dietary fat can 
influence insulin binding and action. Several researchers 
have shown tissues with varying degrees of fatty acid 
unsaturation to have different insulin binding properties. 
Ginsberg et al. (1982) and Gould et al. (1982) have 
demonstrated that plasma membranes of erythrocytes with a 
greater percentage of lipid as saturated fatty acids had 
decreased insulin receptor number and increased binding 
affinity. No measure of insulin action, however, was 
reported in these studies. In cultured 3T3-L1 cells, 
decreased insulin binding and insulin action accompanied an 
increase of saturated fatty acids in membranes (Grunfeld et 
al., 1981). Fatty acid composition of hepatocytes also 
affects properties of the insulin receptor (McCaleb and 
Donner, 1981). Because tissues react differently to varying 
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degrees of unsaturation, tissues need to be studied 
separately. 
In addition to using dietary regime to hinder NIDDM 
formation, dietary treatment is used to help maintain IDDM 
patients at pseudo-normal glucose and lipid concentrations. 
High carbohydrate diets improve glucose tolerance of 
diabetic patients or animals (Olefsky and Saekow, 1978; 
Simpson et al., 1979; Portha et al., 1982). High 
carbohydrate diets, however, result in an increase in plasma 
triglyceride and a decrease in plasma cholesterol 
concentrations in patients with IDDM (Hollenbeck et al., 
1985). High fat diets also lead to insulin resistance, 
which is already a problem in diabetics (Lavau et al., 
1979). Thus, the issue on amount of dietary fat is 
unresolved. Effect of dietary saturated or unsaturated fat 
in diabetics has not been studied as of yet. Reaven (1986) 
stated in a review on dietary treatment of diabetics, "Based 
upon the data reviewed in this presentation, it seems that 
this advice is, at best, unlikely to have any useful 
metabolic effect, and, at worst, may aggravate the defects 
in carbohydrate and lipoprotein metabolism present in 
diabetes. The only conclusion consistent with this point of 
view is that widespread changes in dietary recommendations 
be avoided until they can be strongly supported by rigorous 
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data. What is required is less advice and more 
information." 
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EXPLANATION OF DISSERTATION FORMAT 
This dissertation has been prepared according to the 
alternate dissertation format as described in the Iowa State 
University Graduate College Thesis Manual. Use of this 
format involves the presentation of two or more sections, 
each of which is in a form suitable for publication in a 
scientific journal. Two independent papers have been 
prepared from the data collected from research performed in 
partial fulfillment of the requirements for the Ph.D. 
degree. A general discussion will follow the papers. 
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SECTION I. EFFECTS OF DIETARY BEEF TALLOW AND SOY OIL 
ON GLUCOSE AND INSULIN HOMEOSTASIS 
IN NORMAL AND DIABETIC PIGS 
56 
ABSTRACT 
To evaluate whether dietary fats that are greatly 
different in saturation of fatty acids can alter glucose 
homeostasis in normal and diabetic animals, 6-week-old 
normal and alloxan-diabetic pigs were fed diets containing 
either beef tallow (saturated) or soy oil (unsaturated) as 
the primary source of fat for 6 weeks. After an 
intra-arterial and oral dose of glucose, pigs fed soy oil 
had greater plasma insulin concentrations than did pigs fed 
soy oil, even though pigs fed different dietary fats had 
similar concentrations of plasma glucose. Insulin 
sensitivity and glucose effectiveness were determined from 
the intra-arterial glucose tolerance test by using a 
mathematical model for glucose-insulin dynamics. Feeding 
beef tallow to normal pigs did not affect insulin 
sensitivity and increased glucose effectiveness (0.07 versus 
0.05 min"l) (P<0.03) when compared with normal pigs fed soy 
oil. After consumption of a meal, concentrations of 
triglyceride (P<0.01), free fatty acids (P<0.05), and 
gastric inhibitory polypeptide (GIF) (P<0.04) in plasma were 
greater in diabetic pigs than in normal pigs. No dietary 
differences were found in plasma triglyceride and free fatty 
acid concentrations after a meal in either normal or 
diabetic pigs. No dietary effect was detected for GIP 
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concentrations in normal pigs. Diabetic pigs fed soy oil 
had approximately 80% greater GIF concentrations for the 8 
hours after the meal than did pigs fed beef tallow (P<0.05). 
Our results suggest that dietary saturated and unsaturated 
fat could be an important regulator of glucose homeostasis 
in normal and diabetic pigs. 
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INTRODUCTION 
Although saturated and polyunsaturated dietary fats may 
affect processes related to glucose homeostasis, the 
mechanism by which degree of unsaturation of dietary fatty 
acids regulates plasma glucose concentrations is poorly 
understood. In rats, dietary saturated fat leads to both 
increases (Hulsmann and Kort, 1983) and decreases in insulin 
concentrations (Hennig and Dupont, 1983; Weekes et al., 
1986). The differences in insulin concentrations between 
animals fed different fats could be a result of changes in 
secretion or action of insulin. Different types of dietary 
fat can affect insulin secretion through different insulin 
secretogues; Hulsmann and Kort (1983) found that rats fed 
saturated fat have elevated concentrations of the insulin 
secretogue, gastric inhibitory polypeptide (GIF), in 
response to a meal (Falko et al., 1975; Williams et al., 
1981). Additionally, diet-induced alterations in fatty acid 
composition of plasma membranes could alter insulin action 
in tissues; increasing the degree of fatty acid unsaturation 
in plasma membrane of cultured cells (Ginsberg et al., 1981; 
Gould et al., 1982) and cells of intact animals (Ginsberg et 
al., 1982) increases receptor number but decreases receptor 
affinity for insulin in some, but not all (McCaleb and 
Donner, 1981; Bar et al., 1984), studies, thereby affecting 
59 
insulin action. Thus, dietary saturated and polyunsaturated 
fat could affect both insulin secretion and insulin action. 
The objective of the present study was to determine the 
effect of a diet high in saturated fat (beef tallow) and a 
diet high in polyunsaturated fat (soy oil) on regulation of 
plasma glucose and insulin homeostasis. In addition, effect 
of type of dietary fat on glucose homeostasis with minimal 
influence of insulin were studied in pigs made diabetic by 
alloxan injection. 
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MATERIALS AND METHODS 
Animals 
Twenty crossbred male pigs were purchased in groups of 
four littermates at approximately 6 weeks of age. Five 
replicate experiments were conducted over a period of 12 
months. Each replicate consisted of two normal and two 
diabetic pigs, with one pig in each group being fed beef 
tallow-containing diets and the other pig in each group 
being fed soy oil-containing diets. Before the experiment, 
pigs were housed in individual pens and offered a commercial 
starter feed and water ad libitum. When pigs weighed 18 kg, 
catheters were implanted into the femoral artery of each 
pig, with the catheter end positioned in the aortic arch. 
Four days after catheterization, 10 of the 2 0 pigs were 
injected intra-arterially with alloxan at a dose of 125 
mg/kg body weight. Alloxan was administered as a 20% 
solution in a sodium citrate (0.1 M):sodium phosphate (0.2 
M) buffer, pH 4.0 (Dawson et al.,1969). 
Diabetic pigs were maintained by subcutaneous injection 
of porcine insulin that was administered immediately after 
each meal. Pigs were given 5-20 Units of Regular insulin 
(Iletin I Insulin, Lilly, Indianapolis, IN) with the morning 
meal. In the evening, pigs were given 5-25 Units of Regular 
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insulin and 10-40 Units of NPH long-lasting insulin (Iletin 
1 Insulin, Lilly, Indianapolis, IN). 
Insulin doses were usually less than required for the 
two days after diabetes induction to insure that 
hypoglycemia did not occur; initial doses consisted of 8 
Units of Regular insulin and 12 Units of NPH insulin. For 
the first week after diabetes induction, insulin doses were 
adjusted daily. If plasma glucose concentrations were 
greater than 240 mg/dl plasma, insulin doses were increased 
2 Units with each meal until the proper insulin dose was 
reached; if plasma glucose concentrations were less than 240 
mg/dl plasma, insulin doses were decreased 4 Units. After 1 
week, insulin doses were adjusted on a weekly basis. 
Diets 
One week after catheterization of normal pigs and 1 
week after alloxan-treatment of diabetic pigs, dietary 
treatments were begun. Dietary ingredients are shown in 
Table 1. Pigs were fed corn-based diets supplemented with 
either beef tallow or soy oil. Lean ground beef was the 
primary source of protein. Fat made up 41% of total 
calories; carbohydrate and protein made up 42% and 17% of 
total calories, respectively. Vitamins and minerals were 
supplemented to meet requirements established by the 
National Research Council (1979) for growing pigs. 
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Table 1. Ingredient composition of diets 
Diet 
Ingredient 
Beef tallow Soy oil 
— — — 
% of dry matter 
Ground shelled corn 61.00 61. 00 
Ground beef^ 18.60 18. 60 
Soybean oil^ 0.00 15. 30 
Beef tallow^ 15.30 0. 00 
Crystalline cholesterol^ 0.01 0. 02 
Vitamin-mineral 5.08 5. 07 
supplement® 
Blowa State University Meats Laboratory, Ames, lA. 
^Edsoy, Staley Mfg. Co., Decatur, IL, donated through 
the courtesy of T. Bessler. 
^Beef tallow was prepared by Iowa State University 
Meats Laboratory, Ames, lA. 
^Crystalline cholesterol was purchased from J.T. Baker 
Co., Phillipsburg, NJ. 
^Supplements were added so that diets contained these 
nutrient concentrations, expressed as percentage or 
amount/kg diet (dry-matter basis); Ca, 1.28%; P, 1.11%; 
Na, 0.33%; CI, 0.49%; K, 0.32%, Mg, 0.09%, Fe, 121.9 mg; 
Zn, 174.1 mg; Mn, 57.5 rag, Cu, 11.6 mg; I, 9.3 mg; Se, 0.2 
mg; retinol, 22130 lU; cholecalciferol, 3410 lU; 
a-tocopherol, 32 lU; 2-methyl-l,4-naphthoquinone, 13.7 lU; 
riboflavin, 18.5 mg; niacin, 123.0 mg; pantothenic acid, 
56.4 mg; cyanocobalamin, 136.7 mg; choline, 1388 mg; 
thiamine, 6.2 mg; pyridoxine, 8.2 mg; biotin, 0.1 mg; and 
folacin, 0.8 mg. 
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Crystalline cholesterol was added to diet to simulate amount 
of cholesterol that average adult Americans consume (Fisher 
et al., 1985) and to equalize amount of cholesterol fed to 
pigs on the two diets. Pigs were fed twice daily, and water 
was available at all times. Amount of feed was adjusted 
weekly so that daily consumption was 40 g dry matter per kg 
body weight. 
Nutrient composition of diets is shown in Table 2. 
Samples of diets were collected every month and stored at 
-20°C. Protein, fat, and cholesterol concentrations were 
determined in lyophilized samples. 
Intra-arterial Glucose Tolerance Tests 
Glucose tolerance tests were performed on pigs after 6 
weeks of dietary treatment. Diabetic pigs received their 
final injection of Regular insulin 24 hours and NPH insulin 
40 hours before the tolerance test. Two blood samples were 
taken approximately 15 minutes before the injection of 
glucose to determine basal glucose and insulin 
concentrations. Glucose in a 50% solution (350 mg/kg body 
weight) was injected through the femoral artery catheter 
into the aorta at approximately 8 a.m. Serial blood samples 
were taken from the arterial catheter for the next 3 hours; 
samples were taken every minute for the first 19 minutes. 
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Table 2. Intake and nutrient composition of diets^ 
Diet 
Component analyzed 
Beef tallow Soy oil 
Dry matter (DM), % 64.4 64.0 
Intake, g DM/kg bwtb*day 40.0 41.0 
Gross energy, kcal/kg DM 5242.0 5293.0 
Protein, % DM 
I—t o
 
(M 
20.6 
Fat, % DM 20.8 21.3 
Ash, % DM 4.2 4.2 
Cholesterol, % DM 0.05 0.05 
Component Calculated percentage of calories 
Corn 49.8 49.7 
Ground beef 19.3 19.3 
Soy oil 0.0 31.0 
Beef tallow 30.9 0.0 
^Polyunsaturated fat to saturated fat ratio (w/w) was 
calculated from published values of fatty acid composition 
of soybean oil, beef tallow, and corn oil (Naito, 1982). 
Ratio for beef tallow diet was 0.65, and ratio for soy oil 
diet was 3.41. 
bbwt = body weight. 
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every other minute until 59 minutes, every 10 minutes until 
120 minutes, and then at 150 and 180 minutes after glucose 
injection. Blood was placed into centrifugation tubes 
containing disodium ethylenediamine tetraacetate (EDTA; 15 
mg/10 ml blood) and sodium fluoride (6 ug/10 ml blood). 
Plasma was recovered by centrifugation at 7700 x y for 20 
minutes at 4°C and was stored at -20Oc until analysis. 
Insulin Sensitivity and Glucose Effectiveness 
A mathematical model of glucose-insulin dynamics, 
developed by Bergman et al. (1979), was used to determine 
insulin sensitivity and glucose effectiveness from 
intra-arterial glucose tolerance studies done in normal 
animals. Model parameters were evaluated by using two IMSL 
subroutines from the IMSL Library. A Runga-Kutta routine 
(DVERK) (IMSL, 1984a) was used to numerically integrate the 
differential equations, whereas a Marquardt-Levenberg 
regression routine (ZXSSQ) (IMSL, 1984b) fitted the model 
unknowns. Three parameters were determined: insulin 
sensitivity, glucose effectiveness, and initial glucose 
concentration. 
The same model was used to characterize the response of 
diabetic pigs during glucose tolerance studies, except that 
the endogenous insulin contributions were set to zero. This 
model was integrated analytically, and values of glucose 
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effectiveness and initial glucose concentration were 
determined by using the NLIN program of the Statistical 
Analysis System (SAS, 1982). 
Response to a Meal Study 
After 7 weeks of dietary treatment, "response to a 
meal" studies were performed on pigs. Diabetic pigs 
received their final injection of Regular insulin 24 hours 
and NPH insulin 40 hours before the response to a meal 
study. Basal blood samples were collected 15 minutes before 
feeding. At approximately 8 a.m., pigs were fed their 
normal morning meal. Blood was collected into 
centrifugation tubes containing EDTA, EDTA and sodium 
fluoride, or EDTA and Trasylol (500 lU/ml plasma, Mobay 
Chemical Company, New York, NY). Samples were collected 
every 15 minutes for 2 hours starting 15 minutes after pigs 
began to consume their meal, every 30 minutes until hour 5, 
and then every hour until hour 8. 
Plasma Membrane Fatty Acid Composition of Liver 
Liver was collected after pigs were killed by magnesium 
sulfate injection. Liver was stored at -2 0°C until 
analysis. Plasma membranes were isolated by differential 
centrifugation (Hollenberg and Cuatrecasas, 1976), and fatty 
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acid composition of isolated plasma membranes was determined 
by gas-liquid chromatography (Arrendale et al., 1983). 
Chemical Analyses 
Diet Gross energy of diets was determined by bomb 
calorimetry (Parr Oxygen Bomb Calorimeter, Model 1231, Parr 
Instrument Co., Inc., Moline, IL). Protein content was 
determined by the Kjeldahl method (N x 6.25, Association of 
Official Analytical Chemists, 1975). Total fat content was 
determined gravimetrically after extraction with 
chloroform:methanol;water (10:20:8; v:v:v) (Bligh and Dyer, 
1959), and cholesterol concentrations were determined 
enzymatically (Omodeo Sale et al., 1984). 
Plasma samples Plasma glucose concentrations of all 
pigs were assayed enzymatically (Glucostat, Worthington 
Biochemicals, Freehold, NJ); plasma insulin concentrations 
were assayed by radioimmunoassay (Trenkle, 1970). Samples 
for assay of GIP were stored with Trasylol and were assayed 
by radioimmunoassay (Kuzio et al., 1974). Plasma samples 
that contained EDTA were assayed enzymatically for 
concentrations of triglycerides (Triglycerides 500 nm, Sigma 
Diagnostics) and free fatty acids (Shimizu et al., 1979). 
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Statistical Methods 
Data were analyzed as a 2 x 2 factorial design. Data 
from glucose tolerance tests and response to a meal studies 
were analyzed by using a split-plot design with treatments 
as main plot effects and time as a subplot effect (Snedecor 
and Cochran, 1980b). Treatment mean squares were tested 
against mean squares for pigs within treatments to reduce 
animal-to-animal variation. Effects of time and 
treatment-by-time were tested against residual mean square 
by using conservative degrees of freedom. Differences in 
treatment-by-time effects indicated that the slopes of data 
curves were different between treatments. Insulin 
concentrations were measured only in normal animals, so, for 
this variable, treatments consisted only of the two types of 
fat. Data for concentrations of metabolites at each 
sampling time and composition of fatty acids were analyzed 
for main effects and interaction by using analysis of 
variance (Snedecor and Cochran, 1980a). Percentages of 
fatty acids also were analyzed with Duncan's multiple range 
test of the Statistical Analysis System (SAS, 1982). 
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RESULTS 
Growth and Concentrations of Plasma Glucose and Insulin 
Weekly body weights of pigs appear in Figure 1. Normal 
pigs gained weight at a faster rate than did diabetic pigs 
(P<0.02). Thus, at week 6, normal pigs weighed 25% more 
(P<0.01) than did diabetic pigs. Type of dietary fat did 
not affect weight gain in normal or diabetic pigs. 
Plasma glucose and insulin concentrations were 
determined in 16-hour fasted pigs every 2 weej^g;^after, 
initiation of dietary treatment; data appear in Table 3. 
Even though diabetic pigs had been given exogenous insulin 
at the time of sampling, diabetic pigs had almost threefold 
greater plasma glucose concentrations than did normal pigs 
(P<0.01). Type of dietary fat had no effect on plasma 
glucose concentrations in normal or diabetic pigs. A trend 
was found (P<0.15) for plasma insulin concentrations of pigs 
fed beef tallow to be greater than those of pigs fed soy oil 
(4.88+0.91 versus 3.30+0.30 uUnits/ml) after 6 weeks of 
dietary treatment. Plasma insulin concentrations seem to 
increase either with age or dietary treatment. 
Intravenous Glucose Tolerance Tests 
Plasma glucose concentrations before and after an 
intra-arterial (lA) glucose injection in normal and diabetic 
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Figure 1. Growth of normal and diabetic pigs fed beef 
tallow- or soy oil-containing diets. Standard 
error of the mean (SEM) for all treatments at 
all time points is indicated 
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Table 3. Plasma glucose and insulin concentrations . 
in normal and diabetic pigs fasted 16 hours^ 
Time fed diets (weeks) 
Type of pig 
Dietary fat 0 2 4 6 
Normal pig Glucose 
(mg/dl) 
Beef tallow 
Soy oil 
96.2+7.5 
93.7T9.0 
98.2+4.2 103.6+9.0 
99.9+8.1 98.3+6.5 
105.4+2.3 
100.9+2.5 
Diabetic pig 
Beef tallow 
Soy oil 
459+87 
435+56 
357+50 302+24 
290+20 281+18 
270+31 
255+42 
Normal pig Insulin 
(uU/ml) 
Beef tallow 
Soy oil 
1.75+.58 
1.53+0.72 
2.91+1.00 3.36+0.47 
2.23+0.4S 3.88+0,82 
4.88+0.91 
3.30+0.30 
^Concentrations are means + SEM. 
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pigs are presented in Figure 2A. Data from only the first 
60 minutes are presented; diabetic pigs had basal or zero 
time glucose concentrations that were approximately 
threefold greater than those of normal pigs (P<0.02). 
Furthermore, diabetic pigs removed lA glucose from plasma 
more slowly than did normal pigs (diabetes-by-time effect, 
P<0.01). Type of dietary fat did not alter the rate of 
removal of administered glucose in either normal or diabetic 
pigs. 
Concentrations of plasma insulin in normal pigs in 
response to an lA dose of glucose appear in Figure 2B. Over 
the 180-minute sampling period, no significant effect of 
dietary fat or diet-by-time was observed in plasma insulin 
concentrations after an lA dose of glucose. Integrated area 
under the curve, which is representative of average insulin 
concentrations, tended (P<0.14) to be greater for pigs fed 
soy oil than those fed beef tallow (502+41 versus 362+76 
uUnits/ml) for 0 to 23 minutes after lA injection of 
glucose. Concentrations of insulin in plasma, however, were 
different between pigs fed different fats at 1, 2, and 4 
minutes after lA glucose and were 18.6+4.9 versus 43.6+16.3, 
27.4+2.3 versus 40.5+8.7, and 18.5+5.4 versus 33.8+8.8 
uUnits/ml for beef tallow- versus soy oil-fed pigs, 
respectively. 
Figure 2. Plasma glucose and insulin concentrations after 
an IV dose of glucose in normal and diabetic 
pigs fed beef tallow- or soy oil-containing 
diets. Differences between normal pigs fed beef 
tallow and normal pigs fed soy oil are indicated 
by "a" (P<0.08). Standard error of the mean 
(SEM) for all treatments at all times is 
indicated. 
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Plasma insulin concentrations also were determined in 
diabetic pigs at 0, 4, and 59 minutes after lA glucose; 
insulin concentrations after the glucose injection were 
1.11+0.11 versus 1.22+0.38, 1.14+0.10 versus 1.17+0.22, and 
0.85+0.20 versus 1.16+0.28 uUnits/ml for beef tallow- and 
soy oil-fed diabetic pigs at 0, 4, and 59 minutes, 
respectively. 
Mathematical Model for Glucose-Insulin Dynamics 
Insulin sensitivity, glucose effectiveness, and initial 
glucose concentrations appear in Table 4. Insulin 
sensitivity in normal pigs was not influenced significantly 
by dietary treatment because of the large variation between 
pigs. Glucose effectiveness, the ability of elevated plasma 
glucose concentrations to affect the disappearance of plasma 
glucose, was 32% greater in normal pigs fed beef tallow than 
in normal pigs fed soy oil (P<0.03). No dietary effect was 
detected in diabetic pigs. Initial plasma glucose 
concentrations, determined as a parameter of the model and 
defined as extrapolation of the data curve for glucose 
disappearance to 0 time, also was greater (8.3%) for normal 
pigs fed beef tallow (P<0.06). No differences were detected 
in initial glucose concentrations of diabetic pigs fed 
different dietary fats. 
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Table 4. Insulin sensitivity, glucose effectiveness, and 
initial glucose concentrations of normal and 
diabetic pigs&'b 
Type of pig Insulin 
Dietary fat sensitivity 
1000 X ml/minxuU 
Glucose 
effectiveness 
min"i 
Normal pigs 
Beef tallow 
Soy oil 
Diabetic pigs 
Beef tallow 
Soy oil 
14.5+6.1 
6.4+1.2 
N . D . C  
N.D. 
0.071+.006 
0.054+.003 
** 
** 
0.032+.012 
0.026+.004 
Initial 
glucose 
concentrations 
mg/dl 
292.6+7.1' 
270.3+7.1^ 
576.0+41.8 
614.1+75.1 
^Initial glucose concentrations are plasma glucose 
concentration determined after extrapolating the data 
curve for glucose disappearance to 0 time. 
^Values are means + SEM. 
CN.D. = not determined. 
*Dietary fat effects within type of pig are different 
(P<0.06). 
**Dietary fat effects within type of pig are different 
(P<0.02). 
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Response to a Meal Study 
Concentrations of plasma glucose after consumption of a 
meal in normal and diabetic pigs are presented in Figure 3A. 
Throughout the 480 minutes after the meal, plasma glucose 
concentrations were threefold to fourfold greater in 
diabetic pigs than in normal pigs (P<0.02). Furthermore, a 
diabetes-by-time interaction was detected (P<0.03); no 
effect of diet-by-time was found. 
Insulin concentrations in plasma of normal pigs after 
consumption of experimental diets are shown in Figure 3B. 
Concentrations were greater in plasma of pigs fed soy oil 
than in pigs fed beef tallow at 240 (10.9+2.1 versus 
19.2+3.5), 270 (10.7+1.4 versus 17.6+4.5), 300 (9.7+1.6 
versus 17.1+3.2), and 420 (6.5+0.4 versus 10.1+1.6 
uUnits/ml) minutes after consumption of the meal (P<0.07). 
Concentrations before 240 minutes were similar. No 
diet-by-time interaction was observed. 
Plasma triglyceride concentrations after consumption of 
a meal are shown in Figure 4. Diabetic pigs had twofold to 
fourfold greater concentrations of plasma triglycerides than 
did normal pigs for 480 minutes after consumption of the 
meal (P<0.01). In addition, diabetic pigs had a more 
exaggerated response of plasma triglycerides to consumption 
Figure 3. Plasma glucose and insulin concentrations after 
consumption of a meal of beef tallow- or soy 
oil-containing diets in normal and diabetic 
pigs. Differences between normal pigs fed beef 
tallow and normal pigs fed soy oil are indicated 
by "a" (P<0.07). Standard error of the mean 
(SEM) for all treatments at all times is 
indicated. 
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Figure 4. Plasma triglyceride concentrations after 
consumption of a meal of beef tallow- or soy 
oil-containing diets in normal and diabetic 
pigs. Differences between normal pigs fed beef 
tallow and normal pigs fed soy oil are indicated 
by "a" (P<0.08). Differences between diabetic 
pigs fed beef tallow and diabetic pigs fed soy 
oil are indicated by "b" (P<0.07). Standard 
error of the mean (SEM) for all treatments at 
all times is indicated 
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of a meal than did normal pigs (P<0.05). Triglyceride 
concentrations at 0, 15, and 30 minutes after consumption of 
the meal were less in normal soy oil-fed pigs than in normal 
beef tallow-fed pigs (P<0.08); concentrations of plasma 
triglyceride were 137+35 versus 62+8, 155+65 versus 55+12, 
and 184+62 versus 62+3 mg/dl for beef tallow- and soy 
oil-fed pigs, respectively. The only dietary effect in 
diabetic pigs occurred at 180 minutes after consumption of 
the meal; pigs fed soy oil had greater concentration of 
triglyceride (P<0.09) than did pigs fed beef tallow. 
Diabetic pigs had twofold to threefold greater 
concentrations of free fatty acids than did normal pigs 
throughout the 480 minutes after eating (P<0.05) (Figure 5). 
A significant diabetes-by-time interaction was observed 
(P<0.05) such that concentrations of plasma free fatty acids 
tended to increase in diabetics, whereas free fatty acid 
concentrations tended to decrease in normal pigs after 
consumption of the meal. No dietary effect was found in 
plasma free fatty acid concentrations of pigs during the 480 
minutes after meal consumption. 
Plasma GIP concentrations during the 480-minute period 
after the meal are presented in Figure 6. Diabetic pigs had 
approximately threefold greater concentrations of GIP than 
did normal pigs from 60 to 480 minutes after meal 
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Figure 5. Plasma free fatty acid concentrations after 
consumption of a meal of beef tallow- or soy 
oil-containing diets in normal and diabetic 
pigs. Standard error of the mean (SEM) for all 
treatments at all times is indicated 
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Figure 6. Plasma GIP concentrations after consumption of 
a meal of beef tallow- or soy oil-containing 
diets in normal and diabetic pigs. Differences 
between diabetic pigs fed beef tallow and 
diabetic pigs fed soy oil are indicated by "a" 
(P<0.08). Standard error of the mean (SEM) for 
all treatments at all times is indicated 
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consumption (P<0.04). Moreover, a diabetes-by-time 
interaction was observed in that GIF concentrations in 
plasma of diabetic pigs increased more than did those in 
normal pigs after consumption of a meal (P<0.05). Type of 
dietary fat did not influence GIF concentrations in normal 
pigs. Diabetic pigs fed soy oil, however, had greater 
average GIF concentrations (2084+235 pg/ml) than did pigs 
fed beef tallow (1407+183 pg/ml) (P<0.05). 
Plasma Membrane Fatty Acid Composition 
Composition of fatty acids in plasma membranes from 
livers of normal and diabetic pigs fed the two types of fat 
is presented in Figure 7. Fatty acids that were measured 
were palmitate (016:0), palmitoleate (C16;l), stearate 
(C18:0), oleate (C18:l), and linoleate (C18:2). Type of 
dietary fat affected proportions of long-chained fatty acids 
in plasma membrane in all pigs. Figs fed beef tallow had a 
greater percentage of membrane fatty acids as C16:0 
(P<0.01), C16:l (F<0.07), and C18:l (P<0.001) and a lesser 
percentage as C18:0 (P<0.02) and C18:2 (P<0.001) when 
compared with pigs fed soy oil. Diabetic pigs had a greater 
percentage of fatty acids as C18:l (P<0.03) than did normal 
pigs. Diabetes did not affect the percentage of C16:0, 
C16:l, C18;0, and C18;2. Total lipid and cholesterol 
concentrations in liver preparations were not determined. 
Figure 7. Composition of long chain fatty acids in hepatic 
plasma membranes of normal and diabetic pigs fed 
beef tallow- or soy oil-containing diets. Data 
are presented as a weight percentage of total 
long-chained fatty acids measured. Within a 
specific fatty acid, bars with different letters 
are different (P<0.05). Standard error of the 
mean for each bar is indicated. 
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DISCUSSION 
Response of plasma insulin concentration to exogenous 
stimuli was depressed in pigs fed beef tallow when compared 
with pigs fed soy oil; a smaller rise in plasma insulin 
concentrations in beef tallow-fed pigs was found in response 
to both intra-arterial glucose and a meal when compared with 
insulin concentrations of soy oil-fed pigs, even though 
plasma glucose concentrations were similar. Lower 
concentrations of plasma insulin, as found in beef 
tallow-fed pigs, are indicative of a decrease in secretion 
of insulin by pancreatic beta cells or an increase in 
removal of insulin from circulation by liver. Because 
insulin uptake and degradation by liver is fairly constant 
(Tranberg, 1979), changes in peripheral concentrations of 
insulin are representative of changes in insulin secretion, 
which are influenced by 1) insulin sensitivity of all 
tissues, 2) concentrations of insulin secretogues, and/or 3) 
sensitivity of pancreatic beta cells to insulin secretogues. 
Insulin sensitivity is the amount of insulin needed to 
produce an effect and depends on binding of insulin to its 
receptor and the translation of insulin binding into action. 
If an animal is more insulin sensitive, less plasma insulin 
is required to achieve the same end metabolic result when 
compared with an animal that is less insulin sensitive 
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(Olefsky, 1981). Beef tallow-fed pigs had less plasma 
insulin and similar plasma glucose concentrations in 
response to exogenous stimuli and, thus, seemed to be more 
insulin sensitive than did soy oil-fed pigs. 
Quantitatively, however, insulin sensitivity, as determined 
by the mathematical model of glucose and insulin dynamics 
(Bergman et al., 1979), was similar between pigs fed 
different types of fat. 
Insulin binding and action, and thus insulin 
sensitivity, can be influenced by fatty acid composition of 
plasma membranes (Amatruda and Finch, 1979; Grunfeld et al., 
1981; Ginsberg et al., 1982; Gould et al., 1982; Bar et al., 
1984) . In the present study, fatty acid composition of 
plasma membranes from liver paralleled fatty acid 
composition of dietary fat such that pigs fed unsaturated 
fat had greater concentrations of linoleate and lesser 
concentrations of palmitate and oleate than did pigs fed 
saturated fat. Thus, a decrease in degree of unsaturation 
of plasma membrane fatty acids, as found in beef tallow-fed 
pigs, could lead to greater insulin sensitivity, possibly by 
way of a decrease in insulin receptor number and an increase 
in insulin binding to receptor as proposed by others 
(Ginsberg et al., 1981; Ginsberg et al., 1982; Gould et al., 
1982) . 
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The effect that plasma glucose has on its own removal 
from blood is just as important, if not more so, than is the 
effect of plasma insulin on glucose removal from blood (Ader 
et al., 1985). The ability of glucose to normalize its own 
concentration in plasma at basal concentrations of insulin 
is termed glucose effectiveness and can be quantified with 
the same mathematical model that is used to quantify insulin 
sensitivity (Bergman et al., 1979; Ader et al., 1985). In 
normal pigs, glucose effectiveness was greater in pigs fed 
beef tallow than in those fed soy oil, meaning that plasma 
glucose of pigs fed beef tallow are better able to inhibit 
glucose output by liver and/or enhance its own removal from 
plasma (Ader et al., 1985). The apparent qualitative 
difference in insulin sensitivity between pigs fed different 
types of fat actually could have been an artifact of 
differences in glucose effectiveness between pigs. 
When exogenous insulin was removed from the system, as 
in diabetic pigs, no differences were detected in glucose 
effectiveness between pigs fed the two different types of 
fat; the same trend of dietary effect on glucose 
effectiveness in normal pigs also was present in diabetic 
pigs. A lack of any observed dietary effect on glucose 
effectiveness of diabetic pigs could have been a result of 
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the lack of sensitivity of the mathematical model because of 
low numberical values, making differences undetectable. 
If beef tallow-fed pigs had similar action of insulin 
at lower concentrations, then concentrations of metabolites 
other than glucose, such as triglycerides and free fatty 
acids, should not differ between pigs fed the two diets. 
Indeed, after consumption of a meal, plasma triglyceride and 
free fatty acid concentrations were similar between pigs fed 
different types of fat. Plasma triglyceride concentrations 
of fasted beef tallow-fed pigs, however, were greater than 
were concentrations of fasted soy oil-fed pigs, even though 
plasma insulin concentrations were similar. This 
dietary-induced difference in basal triglyceride 
concentrations could have been a result of increased insulin 
sensitivity of liver or decreased activity of lipoprotein 
lipase activity in tissues of beef tallow-fed pigs than in 
soy oil-fed pigs (Bagdade et al., 1970; Cryer et al., 1978). 
In addition to affecting insulin secretion indirectly 
by way of insulin sensitivity, different types of dietary 
fat also can affect insulin secretion by way of direct 
mechanisms. Dietary fat with different degrees of 
unsaturation could affect fatty acid composition of plasma 
membranes of beta cells of the pancreas, leading to changes 
in insulin or glucose receptor function, and could affect 
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secretion of gastrointestinal hormones, which, in turn, 
would stimulate insulin secretion; the most potent 
insulinotropic gastrointestinal hormone is GIF (Dupre et 
al., 1973; Falko et al., 1975). Hulsmann and Kort (1983) 
found that concentrations of plasma GIF paralleled plasma 
insulin concentrations and were greater in rats fed 
saturated fat in comparison with rats fed unsaturated fat. 
In the present study, type of dietary fat influenced 
GIF concentrations differently in normal pigs than in 
diabetic pigs. Diet did not influence GIF concentrations in 
normal pigs; thus, influence of dietary fat on insulin 
secretion must have been through alterations of other less 
potent insulinotropic hormones or within the pancreatic beta 
cells. In diabetic pigs, those fed soy oil had greater 
concentrations of plasma GIF when compared with pigs fed 
beef tallow. Because plasma triglyceride concentrations did 
not vary to any large extent in diabetic pigs, dietary soy 
oil evidently stimulated GIF secretion to a greater degree 
than did dietary beef tallow in these diabetic animals. By 
deleting the negative feedback inhibition of insulin on GIF 
secretion in soy oil-fed normal pigs (Krarup et al., 1984), 
soy oil-fed diabetic pigs had greater GIF concentrations. 
In summary, dietary beef tallow resulted in an increase 
in glucose effectiveness and a decrease in plasma insulin 
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concentrations in response to exogenous stimuli in normal 
pigs and a decrease in GIF concentrations after consumption 
of a meal in diabetic pigs. The overall results from the 
present experiment suggest that dietary saturated and 
polyunsaturated fats can be an important regulator of 
glucose homeostasis in normal and diabetic pigs. 
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SECTION II. EFFECTS OF DIABETES AND DIETARY SATURATED AND 
UNSATURATED FATS ON VERY LOW DENSITY 
LIPOPROTEIN-CHOLESTEROL HOMEOSTASIS 
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ABSTRACT 
To study effects of diabetes and type of dietary fat on 
very low density lipoprotein-cholesterol (VLDL-CH) 
homeostasis, 6-week-old normal and alloxan-diabetic pigs 
were fed diets containing either beef tallow or soy oil as 
the primary source of fat. After 6 weeks of dietary 
treatment, pigs that had been fed every 4 hours for 48 hours 
were injected with autologous VLDL containing 
radioactively-labeled cholesterol. Blood samples were 
collected repeatedly for the first 30 minutes after 
injection of VLDL and less frequently thereafter. 
Twenty-four hours after injection, pigs were killed, and 
liver, skeletal muscle, adipose tissue, heart, and aorta 
were collected and analyzed. Diabetes caused half-lives of 
the primary component of VLDL-CH disappearance curves to 
double and half-lives of the secondary component to be 
60-fold greater when compared with half-lives of normal 
pigs; pool sizes of both primary and secondary components of 
VLDL-CH disappearance curves were several times greater in 
diabetic than in normal pigs. The primary component 
probably represents VLDL-CH, and the secondary component 
probably represents VLDL-derived cholesterol in other 
lipoprotein classes and tissues in rapid equilibrium with 
VLDL-CH. In normal pigs, dietary beef tallow resulted in a 
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threefold increase in the half-life of both components of 
VLDL-CH disappearance and a similar pool size of both 
components in comparison with dietary soy oil. In diabetic 
pigs, feeding beef tallow fat resulted in a similar 
half-life of the primary component of VLDL-CH disappearance, 
a twofold smaller half-life of the secondary component, a 
threefold larger pool size of the primary component, and a 
similar pool size of the secondary component when compared 
with feeding soy oil. Diabetes resulted in greater 
accretion of plasma cholesterol in liver and other 
extrahepatic tissues analyzed and an increase in cholesterol 
content of liver and skeletal muscle. Feeding beef tallow 
resulted in greater accretion of plasma cholesterol by 
skeletal muscle and less uptake in carcass than did feeding 
soy oil. Net transfer of lipoprotein-cholesterol into 
tissues was influenced by diabetes or dietary fat only in 
liver where diabetes resulted in greater net transfer of 
lipoprotein cholesterol into liver when compared with normal 
pigs. In summary, diabetic pigs exchange VLDL-CH among 
vascular pools more slowly than do normal pigs, and net 
transfer of lipoprotein-cholesterol into tissues seems 
directly related to plasma cholesterol concentrations. 
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INTRODUCTION 
Consumption of saturated fat is often associated with 
atherosclerosis (Mahley, 1979), primarily because of the 
hypocholesterolemic effect of dietary polyunsaturated fat 
when compared with dietary saturated fat. Because fatty 
acid composition of lipoproteins and tissues is altered by 
consumption of saturated fat (Baudet et al., 1984; 
Blomstrand et al., 1985; Renner et al., 1986; Woollett, 
Section I), diet-induced changes in the metabolism of 
lipoproteins could be responsible for observed changes in 
concentrations of plasma and tissue cholesterol and 
triglyceride (Cryer et al., 1978; Walsh et al., 1983; Baudet 
et al., 1984; Spady and Dietschy, 1985). Because VLDL are 
one of the two major triglyceride-containing lipoproteins, 
dietary fats have the potential to affect composition and 
metabolism of VLDL to a large extent (Green et al., 1984). 
Indeed, dietary saturated fat depresses disappearance of 
VLDL and chylomicrons when compared with dietary unsaturated 
fat (Nestel and Scow, 1964; Floren and Nilsson, 1977). 
Lipoprotein metabolism also is regulated by insulin. 
Insulin influences plasma lipid concentrations primarily 
through regulation of VLDL metabolism (Chen et al., 1979; 
Reaven and Greenfield, 1981), and a lack of insulin is 
believed to be one of the primary reasons for decreased 
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catabolism of VLDL in diabetic animals (Chen et al., 1979; 
Reaven and Greenfield, 1981). 
The present experiment was designed to study in vivo 
metabolism of VLDL-CH in nonfasted normal and diabetic pigs 
fed either beef tallow or soy oil. Metabolism of VLDL-CH 
was studied instead of the more commonly studied VLDL-TG 
because VLDL-CH is more of an indication of metabolism of 
the VLDL particle, including transfer of cholesterol from 
VLDL to other lipoproteins and tissues, whereas VLDL-TG 
metabolism is more of an indication of lipase activity (Chen 
et al., 1979; Reaven and Greenfield, 1981). In addition, 
effects of dietary fat on cholesterol deposition in normal 
and diabetic pigs were evaluated. 
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MATERIALS AND METHODS 
Animals and Diets 
Pigs and dietary treatments used in this study have 
been described in Section I. 
Plasma and Lipoprotein Cholesterol and Triglyceride 
Concentrations 
At weeks 0, 2, 4, and 6, pigs were fasted 16 hours, and 
arterial blood samples were collected from catheters of 
pigs. Diabetic pigs were maintained on exogenous insulin at 
the time of sampling. Disodium ethylenediamine tetraacetate 
(EDTA) was used as an anticoagulant, and plasma was 
collected by centrifugation. Lipoproteins were isolated 
from plasma by density gradient ultracentrifugation at 18°C 
(L8-70 ultracentrifuge, Ti 50.3 rotor, Beckman Instruments, 
Inc., Irvine, CA) (Havel et al., 1955). Protein (Bradford, 
1976), cholesterol (Omodeo Sale et al., 1984), and 
triglyceride (Triglycerides 500 nm, Sigma Diagnostics) 
concentrations were determined in plasma, VLDL, LDL, and 
HDL. 
VLDL Labeling 
Forty-nine days after dietary treatment was begun, 35 
ml of blood was collected from each pig after a 16-hour 
fast. Very low density lipoproteins were separated from 
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plasma by density ultracentrifugation (Havel et al., 1955). 
Even though pigs were fasted overnight, chylomicrons seemed 
to be present in this lowest density fraction because the 
cholesterol to triglyceride ratio was very low and, thus, 
was more similar to chylomicrons than to VLDL; henceforth, 
solutions of chylomicrons and VLDL will be referred to as 
VLDL. 
About 50 uCi of [4-1'^C]-cholesterol (55.7 mCi/mmol, 
Amersham, Arlington Heights, IL) was incubated with VLDL 
following the protocol of Schwartz et al. (1978) with the 
following changes. Cholesterol had been tested previously 
for purity, and repurification was not necessary. 
Cholesterol, dissolved in 100 ul of ethanol, was added 
slowly to VLDL and incubated at 30°C for 30 min. The 
radioactively-labeled VLDL-CH solution was dialyzed for 18 
hours against a solution of 0.01% EDTA:0.9% NaCl, pH 7.4. 
Autologous solutions of labeled VLDL were reinjected into 
pigs the same morning that VLDL were removed from dialysis. 
Purity of radioactively-labeled VLDL was verified by 1) 
staining the radioactively-labeled VLDL preparations, 
freshly prepared VLDL, and plasma with Sudan Black, 2) 
separating lipoproteins again by ultracentrifugation, and 3) 
comparing the banding of radioactively-labeled VLDL 
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preparations with those for freshly prepared VLDL and plasma 
(Terpstra et al., 1981). 
VLDL Kinetics 
To maintain steady state conditions for kinetic 
studies, pigs were fed one-sixth of their daily allotment of 
food every 4 hours from day 49 to day 52 after dietary 
treatment was begun. Diabetic pigs received injections of 
Regular insulin (Iletin I Insulin, Lilly, Indianapolis, IN) 
with every other meal on day 49. No injections of insulin 
were given on days 50, 51, and 52. 
Two hours after the morning meal on day 51, 12 ml of 
radioactively-labeled VLDL were injected through the femoral 
artery catheter. Serial blood samples were collected at 1, 
3, 5, 7, 9, 12, 15, 20, 30, 45, 60, 90, 120, 180, 240, 360, 
720, and 1440 minutes after injection of 
radioactively-labeled VLDL. Plasma was collected, and 
lipoproteins were separated from each sample. Cholesterol 
concentrations (Omodeo Sale et al., 1984) were determined in 
all samples. Radioactivity was quantified in plasma, VLDL, 
LDL, and HDL by standard liquid scintillation counting 
techniques (Beckman LS-8000, Beckman Instruments, Inc., 
Irvine, CA) and using a commercial liquid scintillation 
cocktail (Beckman, Ready-Solv EP). Additionally, insulin 
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concentrations were determined in plasma of normal pigs at 
0-time (Trenkle, 1970). 
The decreases in specific radioactivities of VLDL-CH 
((dpm/mg VLDL-CH)/(total dpm injected/kg body weight)) with 
time were fitted to an exponential decay curve for a 
two-pool system for the first 60 minutes after injection of 
radioactively-labeled VLDL by using the NLIN program of the 
Statistical Analysis System (SAS, 1982). Data also were 
analyzed by using one- and three-pool models, but residual 
sum of squares were not improved over those from the 
two-pool model. Half-lives and pool sizes of VLDL-CH were 
determined from specific radioactivity decay curves (Shipley 
and Clark, 1972); half-lives were determined from overall 
turnover rates. Specific radioactivities of cholesterol in 
VLDL, LDL, and HDL also were determined from 60 to 1440 
minutes post-injection. 
Tissue Analyses 
Twenty-four hours after injection of radiolabeled VLDL, 
pigs were killed by magnesium sulfate injection. After 
exsanguination, liver, aorta, heart, bilateral half-carcass 
(including head, skin, and hair but minus kidneys, spinal 
cord, and brain), and samples of skeletal muscle 
(longissimus dorsi) and subcutaneous adipose tissue were 
collected from each pig and weighed. Liver, heart, and 
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half-carcass were ground in a meat grinder, and subsamples 
were frozen with liquid nitrogen and pulverized in a 
blender. 
Samples of each tissue were extracted with 
choloroform:methanol:water (10:20:8; v:v;v) (Bligh and Dyer, 
1959). Amount of total lipid was determined 
gravimetrically. Lipids were saponified, and sterols were 
separated from saponified lipids by modifications of the 
procedure of Bachman et al. (1976) . A known amount of 
[14c]-cholesterol was added to each sample to determine 
recovery of cholesterol in the nonsaponified lipids. After 
heating lipid extracts at 55°C for 20 minutes in 2 ml of 95% 
ethanol and 2 ml of 50% KOH, 5 ml of hexane and 15 ml of 
water were added; then, sterols in the hexane layer were 
separated from saponified lipids in the aqueous fraction. 
The sterol fraction was dried, dissolved in absolute 
ethanol, and quantified enzymatically (Omodeo Sale et al., 
1984). 
Lipids from a second set of tissue samples were 
extracted with chloroform:methanol:water as before. 
Extracts were dried, and scintillation fluid was added to 
samples. Total radioactivity was quantified by standard 
liquid scintilation counting techniques. Net uptake of 
plasma cholesterol in tissues was calculated by dividing 
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specific radioactivity of tissue cholesterol by average 
specific radioactivity of plasma cholesterol for the entire 
24-hour sampling period. 
Statistical Methods 
Concentrations, slopes, and intercepts of VLDL-CH of 
the 2x2 factorial design were analyzed for diet effects 
within a type of pig and for diabetes effects by using a 
Student's t-test (Assaf and Assaf, 1974). Tissue data were 
analyzed for main effects of diet and diabetes and 
interactions by using analysis of variance (Snedecor and 
Cochran, 1980a). Specific radioactivity curves of VLDL-, 
LDL-, and HDL-CH from 60 minutes to 24 hours post-injection 
were analyzed by using a split-plot design with treatments 
as main plot effects and time as a subplot effect (Snedecor 
and Cochran, 1980b). Pigs were nested within treatment to 
reduce animal-to-animal variation; treatment mean squares 
were tested against mean squares for pigs within treatments. 
Effects of time and treatment-by-time were tested against 
residual mean square by using conservative degrees of 
freedom. Treatment-by-time effects indicate that slopes of 
decay curves are different between treatments. 
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In Vivo Kinetic Analyses 
Some common terms of in vivo kinetic analyses need to 
be defined before discussion of the data. A "pool" or 
"compartment" is defined as a specific metabolite 
homogeneously distributed in a given physical environment 
(Gurpide et al., 1963). The amount of metabolite in a 
compartment is its pool size. Therefore, when a metabolite 
is distributed into two distinct physical environments, it 
is considered to be distributed into two pools. If the rate 
of exchange of a given metabolite between two pools is very 
rapid or undistinguishable, the pools are considered as one. 
Associated with each compartment are rate constants for 
influx and outflux of the metabolite, and overall turnover 
rate constants can be determined for each compartment. 
To conduct kinetic analyses, a model must be defined 
that distinguishes important compartments from one another. 
Analyses of lipoprotein kinetics is very complex and has 
been a widely studied field over the past 10 years; as of 
yet, a commonly accepted model for VLDL metabolism has not 
been defined. Data in the present study fit best to a 
two-pool model and are represented as: 
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Pool A is the VLDL-CH pool. The assumption is that 
instantaneous mixing occurs in Pool A after injection of the 
labeled VLDL-CH. Unfortunately, mixing is rarely 
instantaneous. Pool B is representative of all compartments 
that equilibrate rapidly with VLDL-CH, such as other 
lipoproteins and tissues that readily take up 
lipoprotein-cholesterol by way of receptor-mediated and 
receptor-independent processes. If the sampling period was 
longer than 1 hour, a third compartment consisting of slowly 
equilibrating tissues would have been present. Overall rate 
constants for each pool, defined as turnover of VLDL-CH of 
Pool A and turnover of VLDL-derived cholesterol of Pool B, 
were determined from combinations of k^, k2, kg, and k^. 
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RESULTS 
Plasma and Lipoprotein Cholesterol and Triglyceride 
Concentrations 
Cholesterol and triglyceride concentrations were 
determined every 2 weeks in plasma; distribution of the two 
lipids among VLDL, LDL, and HDL of plasma from 
overnight-fasted pigs was determined also. Data from normal 
pigs appear in Table 1. At weeks 4 and 6, normal pigs fed 
beef tallow had approximately 30% greater (P<0.10) 
concentrations of cholesterol in plasma and in HDL and 
approximately 45% greater (P<0.10) concentrations in LDL. 
Concentrations seemed to decrease with time in soy oil-fed 
pigs and remained constant over time in beef tallow-fed 
pigs. Triglyceride concentrations were greater in plasma, 
VLDL, and LDL of beef tallow-fed than in soy oil-fed pigs by 
week 6 (P<0.10). Ratios of lipid to protein did not differ 
between diets; ratios for VLDL, LDL, and HDL were 7.59+0.62 
versus 7.00+1.01, 1.82+0.30 versus 1.54+0.19, and 0.09+0.02 
versus 0.07+0.02 for beef tallow- versus soy oil-fed normal 
pigs, respectively, by week 6. Ratios of LDL-CH to HDL-CH 
also were similar between beef tallow- and soy oil-fed 
normal pigs and were 1.76+0.19 versus 1.56+0.18, 
respectively, by week 6. 
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Table 1. Distribution of plasma cholesterol and 
triglycerides among plasma and lipoproteins of 
normal pigs& 
Sample 
Dietary fat 
Time fed diets (weeks) 
Plasma 
Beef tallow 
Soy oil 
121.1+9.9 
122.2+7.2 
Cholesterol 
(mg/dl plasma) 
158.4+14.2 149.2+9.9* 154.3+21 
139.3+14.4 112.8+8.5 129.4+9. 
LDL 
Beef tallow 
Soy oil 
70.4+3.2 94.4+7.2* 82.1+11.0* 83.4+12 
70.3+8.3 72.3+8.2 57.8+4.0 56.8+8. 
HDL 
Beef tallow 
Soy oil 
15.2+2.1 
14.2+0.9 
21.2+1.2 
18.1+2.7 
23.5+1.4' 
15.7+1.8 
18.3+3. 
14.3+1. 
Plasma 
Beef tallow 
Soy oil 
124+12 
109+27 
Triglyceride 
(mg/dl plasma) 
106+21 
88+3 
96+25 
68+9 
120+27* 
64+24 
VLDL 
Beef tallow 81+12 
Soy oil 71+10 
76+12 
66+6 
70+10* 
46+10 
98+22' 
58+8 
LDL 
Beef tallow 16+2 
Soy oil 18+4 
18+6 
10+2 
12+3 
8+2 
14+4' 
8+2 
^Concentrations are means + SEM. 
*Concentrations are different between pigs fed 
different diets (P<0.10). 
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Cholesterol concentrations in plasma and lipoproteins 
of diabetic pigs appear in Table 2. Diabetic pigs were 
receiving exogenous insulin injections at the time of 
sampling. Cholesterol concentrations in plasma and 
lipoproteins usually were similar between pigs fed two 
different diets. Triglyceride concentrations were variable 
(data not shown), and no differences were found in 
triglyceride concentrations between pigs fed the two diets. 
Nonfasted diabetic pigs had approximately a sevenfold 
greater concentration of VLDL-CH than did nonfasted normal 
pigs (P<0.002); see Table 2. No effect of soy oil or beef 
tallow were found in VLDL-CH concentrations in normal or 
diabetic pigs. 
Lipoprotein Kinetics 
To describe the effects of dietary fat and diabetes 
more throughly, several parameters of in vivo kinetics of 
VLDL-CH were calculated from standard equations (Shipley and 
Clark, 1972). Data are presented in Table 3. Intercepts 
and slopes of both components were greater in normal pigs 
than in diabetic pigs (P<0.05). Diabetic pigs fed soy oil 
had greater intercepts of the primary component than did 
diabetic pigs fed beef tallow (P<0.05), and normal pigs fed 
soy oil had greater slopes of the primary component than did 
normal pigs fed beef tallow (P<0.05). Diabetic pigs had 
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Table 2. Distribution of plasma cholesterol among 
plasma and lipoproteins of diabetic pigs® 
Sample 
Dietary fat 
Time fed diets (weeks) 
Plasma 
Beef tallow 
Soy oil 
172+14 
151+13 
Cholesterol 
(mg/dl plasma) 
170+17 
140+10 
160+16* 
129+7 
141+14 
153+25 
LDL 
Beef tallow 
Soy oil 
106+13* 
75+12 
102+15 
76+7 
88+11 
63 + 14 
88 + 11 
75+15 
HDL 
Beef tallow 17+3 
Soy oil 17+2 
14+3 
19+2 
21+3 
17+2 
19+3 
17+3 
^Concentrations are means + SEM. 
*Concentrations are different between pigs fed 
different diets (P<0.10). 
Table 3. Kinetic parameters of VIDL-CH of normal and diabetic pigs fed beef 
tallow- and soy oil-containing diets 
Treatments Effects^ 
Kinetic 
parameter 
Normal 
Beef tallow 
Normal 
Soy oil 
Diabetic 
Beef tallow 
D iabetic 
Soy oil D iab Dlet Int 
Concentration^ , 
Intercept, 1st comp 
Intercept, 2nd comp 
Slope, 1st comp® 
S lope, 2nd comp 
t, , 1st comp 
t^, 2nd comp ^ 
P3O1 size, 1st comp 
2.0+.2 
.4941.116 
.4111.138 
.4101.132 
.1041.023 
2.571ND^ 
2.851ND 
l.llND 
2.11.2 
.5011.250 
.4391.043 
1.2011.676 
.1491.012 
.991ND 
1.081ND 
1.IIND 
15.0+3.2 
.1371.017 
.0071.019 
.1191.029 
.0041.057 
6.15+ND 
69.511ND 
7.2+ND 
16.212.2 
.4221.017 
.0011.001 
.1071.011 
.0021.042 
6.621N0 
173.22+ND 
2.4+ND 
* *  
* *  
* *  
* *  
* *  
*  
*  
ND 
ND 
ND 
Pool size, 2nd comp 1.3±ND 1.2±ND 80.2±ND 63.4±ND ND 
^Values are means ± SEM. 
^Main diabetes and dietary effects and interactions. 
*^ata are presented as mg VIDL-CH/dl VLDL. 
4)ata are presented as specific radioactivity VLDL-CH/dose*kg body weight. 
®Data are presented as minutes. 
%ata are presented as /minute and are representative of half-lives of 
overall turnover rates. 
^ND = not determined. 
^Data are presented as mg VIDL-CH/kg body weight. 
*Effects are different {P<0.05). 
**Effects are different (P<0.01). 
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threefold longer half-lives of the primary component and 
about 60-fold longer half-lives of the secondary component 
of VLDL-CH disappearance than did normal pigs. Feeding a 
highly saturated fat to normal pigs resulted in nearly a 
threefold increase of half-life of both components over that 
of feeding a highly unsaturated fat. In diabetic pigs, type 
of dietary fat did not influence half-life of the primary 
component; half-life of secondary component was two- to 
threefold less than that of soy oil-fed pigs. Diabetic pigs 
had a fourfold and an 18-fold greater pool size of the 
primary and secondary components, respectively, of VLDL-CH 
disappearance than did normal pigs. Pool sizes of the 
primary and secondary components of normal pigs fed 
different fats were similar. In diabetic pigs, pool size of 
the primary and secondary components of beef tallow-fed pigs 
were threefold greater than and similar to, respectively, 
those of soy oil-fed pigs. 
Disappearance/reappearance curves for VLDL-CH of normal 
and diabetic pigs fed beef tallow- and soy oil-containing 
diets are shown in Figure 1. Data are presented as natural 
logarithm of percentage of initial specific activity as a 
function of time after administration of 
radioactively-labeled VLDL-CH. Diabetic pigs fed beef 
tallow had a greater percentage of radioactive cholesterol 
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Figure 1. Natural logarithm of percentage of initial 
specific radioactivity of VLDL-CH as a function 
of time after injection of ^^C-VLDL-CH in normal 
and diabetic pigs fed beef tallow- and soy oil-
containing diets. Standard error of the mean 
(SEM) for all treatments at all times is 
indicated 
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reappear in VLDL during the 1440 minutes after injection 
than did diabetic pigs fed soy oil (P<0.05). No dietary 
effect in normal pigs and no diabetes effect was found in 
reappearance of VLDL-CH. 
Transfer of cholesterol from VLDL into other 
lipoproteins also was observed, and 
disappearance/reappearance curves for LDL-CH and HDL-CH are 
shown in Figures 2 and 3, respectively. A diabetes effect 
was found in specific radioactivity curves of LDL-CH and 
HDL-CH between 60 and 1440 minutes post-injection (P<0.05) 
in that diabetic pigs had 70% more VLDL-derived cholesterol 
reappear in LDL and HDL when compared with that for normal 
pigs. Diet did not affect specific radioactivity curves of 
LDL-CH or HDL-CH. 
A comparison of specific radioactivity curves for 
VLDL-, LDL-, and HDL-CH, based on specific activity values 
of initial VLDL-CH, are shown in Figure 4. Even though 
radioactivity was found in LDL and HDL fractions 1 minute 
after injection of radiolabeled VLDL, specific radioactivity 
of LDL-CH and HDL-CH was very low when compared with 
specific radioactivity of VLDL-CH; specific radioactivities 
of LDL- and HDL-CH were 4% and 1% of specific 
radioactivities, respectively, of VLDL-CH at 1 minute 
post-injection. At 1440 minutes after the injection of 
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Figure 2. Natural logarithm of percentage of initial 
specific radioactivity of LDL-CH as a function 
of time after injection of I'^C-VLDL-CH in normal 
and diabetic pigs fed beef tallow- and soy oil-
containing diets. Standard error of the mean 
(SEM) for all treatments at all times is 
indicated 
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Figure 3. Natural logarithm of percentage of initial 
specific radioactivity of HDL-CH as a function 
of time after injection of ^'^C-VLDL-CH in normal 
and diabetic pigs fed beef tallow- and soy oil-
containing diets. Standard error of the mean 
(SEM) for all treatments at all times is 
indicated 
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Figure 4. Natural logarithm of specific radioactivity of 
VLDL-, LDL-, and HDL-CH as a function of 
time after injection of ^^C-VLDL-CH based on 
specific radioactivity of VLDL-TG in normal and 
diabetic pigs fed beef tallow- and soy 
oil-containing diets. Standard error of the 
mean (SEM) for all treatments at all times is 
indicated 
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radiolabeled VLDL, specific radioactivity of VLDL-, LDL-, 
and HDL-CH accounted for 20%, 55%, and 25% of the total 
radioactivity in plasma. 
Plasma insulin concentrations tended to be greater in 
soy oil-fed pigs than in beef tallow-fed pigs (P<0.18). 
Mean insulin concentrations were 4.14+0.62 and 6.57+1.56 
uUnits/ml of plasma for beef tallow- and soy oil-fed pigs, 
respectively. 
Tissue Analyses 
Percent lipid, amount of cholesterol, amount of 
14c-cholesterol per gram tissue, and net transfer rate of 
plasma cholesterol into tissues are shown in Table 4. Only 
main treatment effects will be discussed here; interactions 
are indicated in Table 4. Liver of diabetic pigs had 
greater percentage of lipid (P<0.04), more 
radioactively-labeled cholesterol (P<0.001), and greater net 
transfer rate of plasma cholesterol (P<0.09) than did liver 
of normal pigs. No main diabetes or dietary effects were 
found in cholesterol content of liver. Skeletal muscle of 
diabetic pigs had more cholesterol per gram of tissue 
(P<0.02) and more radioactively-labeled cholesterol (P<0.02) 
than did muscle of normal pigs. Pigs fed beef tallow had 
more radioactively-labeled cholesterol than did pigs fed soy 
oil (P<0.10). No treatment effects were found in 
Table 4. Kinetic parameters of VIDL-CH of normal and diabetic pigs fed beef 
tallow- and soy oil-containing diets^ 
Treatment Effects 
Tissue 
parameter 
Normal 
Beef tallow 
Normal 
Soy oil 
Diabetic 
Beef tallow 
D iabetic 
Soy oil 
Liver 
weight, % 
lipid. 
CH,.mg 
CH*' 
NT CH*9 
1.96±0.11 
3.93±0.07 
41.41±3.45 
26985±3570 
1854.51146.4 
Skeletal muscle 
lipid, % 3.18±0.33 
CH, mg 12.01±0.30 
CH* 632±87 
NT CH* 43.912.4 
1.8910.25 
4.0210.11 
33.3111.56 
2566812799 
1952.01209.7 
2.7410.32 
1 0 . 2 2 + 1 . 2 2  
449134 
38.914.0 
Subcutaneous adipose tissue 
lipid, % 74.5611.71 78.4311.71 
CH, mg 2.9110.61 3.62+2.10 
CH* 1172+132 1003186 
NT CH* 89.3115.6 79.116.9 
Aorta 
lipid, % 
CH, mg 
CH* 
NT CH* 
1.7210.71 
16.8910.90 
524185 
34.614.5 
1.7610.06 
19.3413.96 
529171 
72.418.0 
2.3410.11 
4.7010.09 
36.0913.21 
51633+4479 
4083.411357.6 
2.22+0.17 
13.54+0.60 
766149 
61.9123.7 
61.85+3.01 
2.98+0.68 
1675+2.61 
96.3129.2 
1.83+0.22 
15.8910.91 
857+92 
47.8+7.8 
Diab Diet Int 
2.3810.13 
4.1210.15 
34.4613.09 
5209315412 
2468.91500.0 
3.4610.20 
13.5011.80 
692193 
34.418.5 
68.5612.20 
1.2910.10 
18481350 
86.3128.5 
1.9810.13 
17.09+0.68 
744174 
36.717.4 
* 
* 
* * 
* 
* * 
* *  
**  
** 
* *  
* *  
Heart 
weight, % 0.43±0.04 0.5010.04 0.43±0.08 0.43+0.04 
lipid, % 3.18±0.15. 3.89+0.27 3.68+0.41 3.50+0.14 
CH, mg 23.6810.51 24.9011.38 24.33+1.08 21.91+1.02 
CH* 28161408 22051180 34561327 35721460 ** 
NT CH* 189.7119.4 171.019.6 193.8133.1 177.6142.3 
Carcass 
lipid, % 16.5010.35 17.6410.40 10.50+0.80 13.60+0.64 ** ** 
CH, mg 37.6512.40 33.30+1.50 42.4312.10 31.9512.35 ** 
CH* 1207+135 818169 15221143 14291196 ** * 
NT CH* 73.918.7 65.518.0 48.2+1.3 72.1118.3 
protein, % 46.0511.25 43.5311.23 53.9611.74 49.2212.11 ** ** 
Plasma . 
CH, Ave SA^ 14.112.6 12.811.6 19.211.7 23.9+2.7 ** 
^Values are means + SEM. 
^Main diabetes and dietary effects and interactions. 
^Data are presented as a percentage of body weight. 
^Data are presented as a percentage of tissue, wet tissue basis. 
^CH, mg = mg cholesterol/100 g tissue, wet tissue basis. 
^CH* = dpm i^C/g tissue, wet tissue basis. 
^NT CH* = net transfer rate of plasma cholesterol/g tissue, wet tissue basis. 
Data are presented as specific radioactivity of cholesterol in g tissue/average 
specific radioactivity of cholesterol in plasma x 1440 minutes. 
^3ata are presented as percentage of tissue, dry matter basis. 
^CH, Ave SA = average specific radioactivity of cholesterol in plasma for the 
24-hour study. 
*Effects are different (P<0.10). 
**Effects are different (P<0.05). 
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percentage of lipid or net transfer rate of plasma 
cholesterol of this tissue. Diabetic pigs had a smaller 
percentage of lipid in adipose tissue (P<0.05) and had less 
radioactively-labeled cholesterol (P<0.005) than did normal 
pigs. In subcutaneous adipose tissue, dietary soy oil 
resulted in greater percent fat (P<0.03) than did dietary 
beef tallow. Net transfer rate of plasma cholesterol into 
adipose tissue was not affected by treatment. Aortas of 
diabetic pigs tended to have a greater percentage of lipid 
(P<0.20) and did have more radioactively-labeled cholesterol 
(P<0.002) than did normal pigs. Neither amount of 
cholesterol per gram aorta or net transfer rate of plasma 
cholesterol were influenced by treatment. Diabetic pigs had 
more radioactively-labeled cholesterol in heart than did 
normal pigs (P<0.007). Treatment did not affect percentage 
of lipid, cholesterol content, and net transfer rate of 
plasma cholesterol in heart. In carcass, pigs fed soy oil 
had greater percentage of lipid (P<0.03), less 
radioactively-labeled cholesterol (P<0.09), less cholesterol 
content (P<0.002), and a smaller percentage of protein 
(nitrogen content x 6.25) (P<0.04) than did pigs fed beef 
tallow. Carcass of normal pigs had a greater percentage of 
lipid (P<0.003), less radioactively-labeled cholesterol 
(P<0.002), and a smaller percentage of protein (P<0.05) than 
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did carcass of diabetic pigs. No treatment effects were 
found in net transfer rate of plasma cholesterol into 
carcass. 
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DISCUSSION 
In the present study, feeding saturated fat to normal 
pigs resulted in hypercholesterolemia and 
hypertriglyceridemia when compared with feeding pigs 
unsaturated fat. Cholesterol concentrations were increased 
uniformly across all lipoprotein classes so that ratios of 
HDL-CH to LDL-CH did not change with diet. Additionally, no 
changes were found in protein to lipid ratios in pigs. 
Thus, different types of dietary fat did not influence 
amount of triglyceride, cholesterol, and protein of each 
lipoprotein particle in these pigs, which agrees with some 
previous studies (Walsh et al., 1983;) and disagrees with 
others (Mahley et al., 1975; Renner et al., 1986). A change 
in fatty acid composition and type of apolipoprotein in 
lipoproteins may have been different between pigs fed 
different types of fat but were not determined. Cholesterol 
and triglyceride concentrations were not affected to a large 
degree by dietary fat in diabetic pigs. 
Literature is replete with studies on VLDL metabolism 
because VLDL metabolism is so closely linked to cholesterol 
and especially to triglyceride concentrations. A number of 
different models have been proposed to explain in vivo 
synthesis, secretion, and catabolism of VLDL (Reardon et 
al., 1978; Zech et al., 1979; Phair, 1982; Green et al.. 
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1984). Different models are used depending on whether 
cholesterol, triglyceride, phospholipid, or protein of VLDL 
is labeled. When cholesterol of VLDL is labeled, as in this 
study, disappearance of label from VLDL is an indicator of 
both receptor-mediated uptake of VLDL by tissues and 
exchange of cholesterol with other lipoproteins and tissues. 
The in vivo kinetics of VLDL-CH metabolism in the 
present study were analyzed by a two-pool model (Shipley and 
Clark, 1972). The primary pool, or component, is 
cholesterol in VLDL. Pool size of this first component was 
similar to concentrations of VLDL-CH in normal pigs and 
diabetic pigs fed beef tallow. Diabetic pigs fed soy oil 
had smaller pool sizes than would be expected from 
concentrations of VLDL-CH, possibly because mixing was not 
as complete in these pigs as in pigs on other treatments. 
Half-lives of the primary pool were rapid (1.3 minutes in 
normal and 6.4 minutes in diabetic pigs) and were an 
indication of removal of cholesterol from VLDL into other 
lipoproteins or tissues. 
The secondary pool of VLDL-CH is actually a combination 
of several different pools that readily exchange cholesterol 
with VLDL-CH, such as other lipoproteins, red blood cells, 
and tissues (Kovanen and Nikkila, 1976; Aigueperse et al., 
1983). The pools that make up the secondary component were 
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"lumped" together because they were indistinguishable from 
one another in the present study. Thus, the secondary pool 
of VLDL-CH is comprised of VLDL-derived cholesterol. 
Disappearance of cholesterol from VLDL and exchange of 
VLDL-CH with other cholesterol pools were drastically 
different between normal and diabetic pigs. The large 
differences in pool sizes and half-lives of the secondary 
pool of VLDL-CH between normal and diabetic pigs indicated 
that the secondary pool was different between the two types 
of pigs. In normal pigs, the small secondary pool probably 
represents cholesterol within the vascular system, such as 
lipoproteins or red blood cells. In diabetic pigs, the 
secondary pool probably represents cholesterol in tissues in 
addition to cholesterol of the vascular system. 
Lipoproteins of normal pigs seem to undergo a rapid, more 
extensive exchange of VLDL-CH with other vascular pools of 
cholesterol than do lipoproteins of diabetic pigs. 
Lopes-Virella et al. (1985) have shown that lipoproteins of 
diabetics are metabolized by tissues slower than are 
lipoproteins of normal animals, possibly because the 
lipoproteins are glycosylated (Steinbrecher and Witzum, 
1984) or have different compositions of fatty acids 
(Lopes-Virella et al., 1985). Thus, the different exchange 
rates of cholesterol within vascular pools of cholesterol 
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between.normal and diabetic pigs also could be a result of 
changes in glycosylation or fatty acid composition of 
lipoproteins. 
Dietary fat, in addition to diabetes, influenced 
VLDL-CH metabolism. In normal pigs, feeding beef tallow 
resulted in longer half-lives of the primary and secondary 
components when compared with feeding soy oil. These 
results are consistent with past research (Nestel and Scow, 
1964; Green et al., 1984) and could be part of the reason 
for the elevated concentration of cholesterol in plasma of 
fasted pigs. Even though half-lives of both components were 
longer in beef tallow-fed pigs, pool sizes of both 
components as well as concentrations were similar between 
pigs fed two different types of fat. From the present 
study, the mechanism that caused the change in half-lives 
with no change in pool size is unknown and occurred during 
the first 6 weeks of dietary treatment of pigs. 
In diabetic pigs, half-life of the initial component of 
VLDL-CH was not affected by diet. Half-life of the second 
component was longer in soy oil-fed pigs than in beef 
tallow-fed pigs, which was opposite of that found in normal 
pigs. Additionally, pool size of the primary pool was 
greater in beef tallow-fed pigs than in soy oil-fed pigs, 
and the pool size of the secondary pool was similar between 
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pigs fed two different types of fat. As stated before, the 
mechanism that caused the change in half-lives and pool 
sizes is unknown and can not be determined from the present 
study. 
Additionally, diabetic pigs fed beef tallow 
recirculated more cholesterol as VLDL than did diabetic pigs 
fed soy oil and, as a possible result, retained more total 
VLDL-derived cholesterol in their body at death (85%) when 
compared with diabetic pigs fed soy oil and normal pigs fed 
either diet (70%). Evidently, diabetic pigs fed beef tallow 
did not remove cholesterol from their bodies as well as did 
other pigs, possibly because of a decrease in synthesis 
and/or secretion of bile acids. In agreement, feeding 
saturated fat to rats also leads to a greater retention of 
cholesterol in their body as a result of depressed secretion 
of bile acids when compared with feeding unsaturated fat (Oh 
and Monaco, 1985). 
A direct result of altered lipoprotein metabolism is a 
change in accretion of cholesterol and triglyceride in 
tissues. Entry of cholesterol, which is one of the primary 
constituents of atherosclerotic plaque, into vascular 
epithelia occurs by way of a combination of de novo 
synthesis, receptor-mediated uptake, receptor-independent 
uptake, and turnover. By knowing specific radioactivity of 
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cholesterol in tissues and plasma, net transfer rate of 
plasma cholesterol into tissues can be estimated. 
Diabetes resulted in more radioactively-labeled 
cholesterol in all tissues of pigs in comparison with 
tissues of pigs that were normal. Greater uptake of plasma 
cholesterol in diabetic animals seems to be a function of 
cholesterol availability in plasma. Greater cholesterol 
content in tissues of diabetic pigs were not found most 
likely because de novo cholesterol synthesis was depressed 
in the diabetic pigs when compared with normal pigs (Brown 
and Goldstein, 1978). When specific radioactivities of 
plasma cholesterol were considered, liver was the only 
tissue of diabetic pigs that had greater net transfer rates 
of plasma cholesterol when compared with tissues of normal 
pigs. Lipoproteins were more available to liver of diabetic 
pigs (Green et al., 1984) as a consequence of slower 
catabolism of lipoproteins by extrahepatic tissues (Chen et 
al., 1979; Reaven and Greenfield, 1981; Lopes-Virella et 
al., 1985), resulting in greater net transfer rates in 
liver. Diabetics recirculated more cholesterol as LDL and 
HDL because they had larger pools of radioactive cholesterol 
in liver to synthesize new lipoproteins with. 
Unlike past studies (Diersen-Schade, 1984; 
Walsh-Hentges et al., 1985; Baldner-Shank, 1986), diet did 
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not influence composition or net uptake of cholesterol by 
tissues to any large degree. The largest influence of 
dietary fat was that pigs fed soy oil had more lipid in 
adipose tissue and carcass. An explanation for the increase 
in percentage of lipid in tissues is that pigs fed soy oil 
may have received more digestible energy than did pigs fed 
beef tallow; saturated fat is less digestible than is 
unsaturated fat (Mattson, 1959; Baldner-Shank, 1986). 
It is commonly believed that the observed changes in 
metabolism between normal and diabetic pigs fed two 
different types of fat could be mediated by compositional 
changes in lipoprotein and plasma membranes. Insulin 
concentrations in plasma, however, are a major stimulus of 
VLDL catabolism and could affect half-lives and pool sizes 
of VLDL. One of the primary ways insulin regulates VLDL 
catabolism is by way of lipoprotein lipase activity (Cryer, 
1981). Others have shown that activity of lipoprotein 
lipase in animals fed unsaturated fat is greater than 
activity of lipoprotein lipase in animals fed saturated fat 
(Bagdade et al., 1970; Cryer et al., 1978), as a result of 
changes in insulin concentrations or fatty acid composition 
of plasma membranes. In the present study, insulin 
concentrations in plasma tended to be greater in soy oil-fed 
pigs. Thus, a lack of plasma insulin in beef tallow-fed 
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pigs could have led to depressed removal of VLDL-CH as seen 
by a longer initial half-life of VLDL-CH when compared with 
pigs fed soy oil; moreover, initial half-lives in diabetic 
animals were not affected by diet and supports this theory. 
In conclusion, the removal of VLDL-CH from circulation 
and exchange of VLDL-CH between vascular cholesterol could 
be dependent on insulin concentrations and other 
diet-induced factors such as fatty acid compostion of 
lipoproteins and plasma membranes. Additionally, net 
transfer of plasma cholesterol into peripheral tissues seems 
to be directly related to availability of plasma 
cholesterol, and net transfer of cholesterol into liver 
seems to be indirectly related to net transfer of 
cholesterol into peripheral tissues. 
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GENERAL DISCUSSION 
The overall conclusion of the present study was that 
dietary saturated and unsaturated fat, when fed for 6 weeks, 
can play an important role in regulation of glucose and 
VLDL-CH homeostasis. Several follow-up experiments could be 
completed to improve and better quantify the results of this 
study and possibly to elucidate the primary effects that led 
to the differences we detected. 
To study glucose homeostasis in greater detail, 
metabolism should be studied in both fasted and fed 
conditions. With constant infusion of radioactively-labeled 
glucose, production rate and clearance of glucose can be 
determined, which would be a better indication of glucose 
homeostasis and glucose effectiveness. In the present 
study, insulin sensitivity could not be quantified as 
accurately as needed; either more than five animals.needed 
to be used or insulin sensitivity should have been 
determined in vitro. Insulin sensitivity is essentially a 
combination of insulin binding and action, and thus, one 
could easily study these parameters in cell preparations. 
Because degree of unsaturation in plasma membranes do not 
affect insulin receptors similarly in different tissues, 
sensitivity should studied in several tissues, such as 
adipocytes, hepatocytes, and erythrocytes. A limitation of 
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the present study was that we could not determine if the 
increase in plasma insulin concentrations throughout the 
study were age- or diet-related. Thus, a control set of 
pigs, possibly pigs on a low-fat diet, should be used in 
follow-up studies. 
Lipoprotein metabolism also can be evaluated to a 
greater extent in follow-up studies than in the present 
study with a few changes in protocol. Because of the lack 
of understanding of in vivo metabolism of lipoproteins, 
models are often oversimplified and much good data are 
"wasted", as was the case with data in this experiment. The 
problem in modeling in this experiment, and in other 
experiments, occurs when pools are "lumped" together. To 
get around some of the problems associated with bolus 
injections of radioactively-labeled lipoproteins, such as 
pool "lumping", one could perform kinetic studies during a 
constant infusion of labeled-lipoproteins. From these 
studies, estimation of production rate and clearance of the 
lipoproteins in fasted and fed conditions could be 
determined and would have more physiological significance 
than does pool size. 
During constant infusions, as during bolus injections, 
lipoproteins are taken up by tissues and catabolized. 
Products of catabolism could be used in synthesis of new 
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lipoproteins and secreted back into the circulation as 
metabolites other than the metabolite injected; for example, 
cholesterol could be converted to cholesterol ester or bile 
acids. Specific metabolites under study should be separated 
from the sample, with digitonin in the case of cholesterol, 
and specific radioactivities determined from those data. 
The choice of pigs as our animal model to use in this 
experiment was excellent. The large size of the pigs 
allowed repeated sampling of blood during glucose tolerance 
studies and measurements of in vivo lipid kinetics. Because 
of our ability to position catheters in the aortic arch, low 
doses of alloxan were used to render pigs diabetic, and our 
success rate for making pigs diabetic was very good. Pigs 
also were fairly easy to maintain, and we did not lose a pig 
from hypo- or hyperglycemia. The only drawback of using 
pigs was that pigs do not metabolize lipoproteins as do 
humans; VLDL-remnants are taken up as such in pigs, and 
VLDL-remnants are converted to LDL in plasma in humans. 
Nevertheless, pigs can and are often used in studies on 
lipoprotein metabolism; care must be taken when 
extrapolating results to humans, however. 
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APPENDIX 
Table Al. Analysis of variance on plasma glucose concentrations after 
consumption of a meal 
Conservative Type III 
Sources of Degrees of Degrees of Sum of Mean 
Variation Freedom Freedom Squares Squares F Value 
Treatment 3 3 14468256 4822752 19.7 
diabetes 1 1 14708260 14708260 60.2 
diet 1 1 30064 30064 0.1 
interaction 1 1 22823 22823 0.1 
Animal(Trt) ^ 16 16 3909161 244322 
Time 17 17 69198 4070 <.l 
Trt*Time 51 3 126735 42245 .1 
diabetes*time 17 1 71295 71295 .1 
diet*time 17 1 20875 20875 <.l 
interaction*time 17 1 24289 24289 <.l 
Error B 272 16 19176353 1198522 
^Animal(Trt) = Error A. 
